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Abstract 
 
Part A 
Dynamic high performance liquid chromatography on chiral 
stationary phases is a consolidated technique that allows the 
investigation of chiral molecules with labile stereogenic 
elements that interconvert very quickly at room temperature 
and result in stereoinversion processes occurring on the time 
scale of the separation process. Kinetic parameters for on-
column interconversions can be extracted from exchange-
deformed experimental peak profiles by computer 
simulation. The technique has been used in a wide range of 
temperatures and is complementary in scope to dynamic 
nuclear magnetic resonance spectroscopy.      
Here we report, in the first part, the separation of the 
enantiomers of benzodiazepines, a class of molecules whose 
conformational enantiomers interconvert not only through a 
single bond rotation but also via ―ring-flip‖ inversion. The 
second part concerns the first HPLC resolution of the 
conformational enantiomers of tri-O-thymotide (TOT) a 
macrocyclic trilactone existing in fast-exchanging multiple 
chiral conformations. Variable chromatography on brush 
type stationary phases showed dynamic features due to on-
column interconversions of TOT. 
 
Part B 
Chiral recognition is a branch of chemistry aimed at 
understanding the reactivity as well as the size- and shape-
specificity of non-covalent interactions between molecular 
aggregates formed by chiral species. Mass spectrometry 
(MS) is a powerful tool for investigating chiral recognition 
in the gas phase in the absence of perturbing environmental 
phenomena and discriminating and even quantifying chiral 
species by interaction with chiral reference molecules.  
A small library of synthetic receptors was prepared by 
macrocyclization of complementary A and B fragments to 
yield A2B2 macrocycles, where A are activated forms of 
isophthalic acid derivatives and B are chiral, C2 symmetric 
1,2-diamines derived from 1,2-diphenylethylendiamine. 
Their enantioselectivity was investigated by ESI-MS and 
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revealed large enantioselectivities towards the enantiomers 
of aminoacids and peptide guests. The stability of the 
complexes increases with the size of guests and with large 
aromatic portions on the guest. 
 
Part C 
This part of my academic program was developed at the 
University of California, Davis, under the supervision of 
prof. Carlito Lebrilla, during the last period of my Ph.D. 
activity. 
An important goal in proteomic is to quantify the profile 
changes of protein abundances in biological systems. 
Quantifying these changes is a key to understand changes in 
cell state at a molecular level. 
In the last years label-free quantitation using MRM 
(multiple reaction monitoring), which correlates the mass 
spectrometric signal of intact proteolytic peptides with the 
relative or absolute protein quantity, is become a powerful 
tool for accurate quantitation. Here we report a label-free 
method to quantify proteins and their glycoforms in biologic 
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fluids (milk, feces and urine) by MRM, including the 
selection of proteotryptic peptides and the optimization and 
validation of transitions. 
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Stereodynamics of chiral stereolabile 
compounds 
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General Introduction 
 
Louis Pasteur, in 1848, was the first to recognize the 
omnipresence and significance of chirality [1]. Today 
chirality can indeed be found at all levels in nature, in the 
form of the elementary particle known as the helical 
neutrino, inherently chiral proteins, carbohydrates and 
DNA, or helical bacteria, plants and sea shells.  
Chiral objects exist as a pair of enantiomorphous mirror 
images that can exhibit different chemical and physical 
properties in a chiral environment. Stereolabile 
conformational enantiomers and diastereoisomers cannot be 
separated at room temperature and spectroscopic or 
chromatographic techniques are often unable to differentiate 
the rapidly interconverting  species. Many biologically 
active compounds, such as pharmaceuticals, agrochemicals, 
flavors, fragrances, and nutrients, are chiral and this  
increases the demand in progress in asymmetric synthesis 
and catalysis, and in the development of analytical 
techniques for the determination of the stereochemical 
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purity of chiral compounds. Stereoselective analysis usually 
entails chiroptical measurements, NMR and mass 
spectroscopic methods, electrophoresis, chiral 
chromatography or UV and fluorescence sensing assays, and 
it can provide invaluable information about the stability of 
chiral compounds to racemization and diastereomerization. 
One of the best way to obtain information in terms of 
enantiomeric composition and to separate enantiomers on 
large scale is represented by HPLC separation of 
enantiomers on chiral stationary phases. High-resolution 
enantioselective chromatography techniques based on the 
utilization of chiral stationary phases, are extremely useful 
for the study of conformational chirality. The simultaneous 
use of  DNMR is of fundamental importance because it 
allows the complete elucidation and assignment of very 
complicated patterns. Separation of enantiomers on chiral 
stationary phases is realized through reversible formation of 
diastereomers, resulting from non-covalent interaction of the 
two enantiomers of the analyte with the chiral selector of the 
Part A 
 
4                                   Ph. D. Thesis 
 
stationary phase. This reversible interaction is usually 
referred to as primary equilibrium (Fig. 1) [2-6]. 
 
Km1 , K
m
-1 : rate costants for the interconversion in the mobile phase  
Ks1: rate costant for the R to S conversion in the stationary phase  
Ks-1: rate costant for the S to R conversion in the stationary phase  
Ka1: apparent rate costant for the R to S conversion  
Ka-1: apparent rate costant for the S to R conversion  
 
Figure 1: Primary and secondary equilibria taking place during 
chromatography of two interconvertible enantiomers R and S on a CSP. 
 
 
The secondary equilibria are related to the reversible 
exchange processes between R and S occurring in the 
mobile and stationary phases. If the mobile phase is achiral 
the two constants k
m
1 and k
m
-1 are equal, the two rate 
constants, k
s
1 and k
s
-1, are different if  R and S have different 
retention times. 
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The apparent rate constants k
a
1 and k
a
-1 thus obtained are 
averaged values for the interconversion occurring in the 
mobile (k
m
1=k
m
-1) and in the stationary (k
s
1≠ k
s
-1) phases. 
Although the values of the apparent rate constants obtained 
by simulation may differ in principle from k
m
, in practice 
they are usually very close to those determined by 
independent measurements in free solution and can be used 
to determine the energy barrier for the dynamic process [7]. 
The equation (1) relates the chromatographic 
enantioselectivity (α) with the energy difference of the 
transient diastereomers.  
 
ΔΔG°2,1=ΔG°2 –ΔG°1= – RT ln(k‘2/k‘1)= –RT lnα2,1         (1) 
 
where ΔΔG°2,1 is the difference in the interaction Gibbs 
energies between the two enantiomers and the selector, R is 
the gas constant, T is the absolute temperature and α2,1 is the 
ratio of the retention factors k‘2 and k‘1 of the two 
enantiomers.  
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Dynamic stereochemistry, in the form of variable 
temperature (for DNM and DHPLC) or variable flow 
chromatography, plays a crucial role in the study of 
stereodynamic processes that can be employed to determine 
the enantiomerization (the reversible isomerization of one 
enantiomer into the other) barrier of chiral stereolabile 
species when the interconversion takes place at the time 
scale of the separation process. A successful 
chromatographic separation of stereoisomers affords two 
distinct peaks. However, stereoisomers may undergo 
interconversion during the chromatographic process at 
elevated temperatures. The competition between resolution 
and isomerization results in an elution profile showing a 
plateau between the peaks. Since plateau formation is due to 
on-column isomerization, both the reaction rate and the 
height of the plateau increase with temperature (Fig. 2). 
When the interconversion process becomes much faster than 
the chromatographic separation, at high temperatures, only 
one peak is observed.  
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Figure 2: Temperature-dependent plateaus and peak coalescence due to 
simultaneous chromatographic resolution and on-column isomerization. 
 
Three different chromatographic scenarios can be observed: 
(a) two baseline-separated peaks are obtained if 
enantiomerization is slow compared to the chromatographic 
time scale; (b) competition between chromatographic 
resolution and enantiomerization generates a temperature-
dependent plateau between the two peaks; and (c) only one 
peak is observed when enantiomerization is fast relative to 
the time required for the separation.  
Computer simulation  of exchange-deformed elution profiles 
gives the apparent rate constants for the on column R/S 
interconversion and the associated barriers Gǂ. 
The interconversion of stereoisomers exhibiting 
diastereotopic nuclei can be monitored by variable-
temperature  NMR  spectroscopy  (dynamic NMR)  when 
Part A 
 
8                                   Ph. D. Thesis 
 
the reaction is slow on the NMR time scale. This is the case 
when: 
k = 
1
𝑡
 ≪ π 
∆𝜈
√2
 
where k is the interconversion rate constant, t is the 
interconversion time (in s) and  is the NMR shift 
separation of the signals (in Hz) at low temperatures at 
which exchange does not occur. This equation indicates that 
same nuclei can show distinct signals when the chemical 
shift difference (Δν) corresponds to a time spent by the 
nuclei in different positions longer than the interconversion 
time t.  Increasing the temperature, increases the exchange 
rate relative to the NMR time scale and only one averaged 
species is observed due to signal coalescence (Fig. 3) [8-9]. 
 
 
 
Figure 3: Variable-temperature NMR spectra.  
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Free Gibbs activation energy ΔGǂ can be calculated in 
kcal/mol from eq. 1 
 
ΔGǂ = 4.58*Tc*[10.32 + log (Tc/kc)]         (Eq. 1) 
The NMR time scale is different from HPLC time scale and 
dynamic spectra are observed across a higher temperature 
range compared to DHPLC.  
DHPLC and DNMR are complementary methods that allow 
kinetic investigations of stereolabile compounds over a wide 
temperature range. DHPLC is well suited for operation in 
the cryo-temperature range (from -80 °C to 0 °C) and in the 
high temperature range (from ambient temperature up to 100 
°C.) 
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PART A-1 
 
 
 
 
 
 
Dynamic HPLC on chiral stationary 
phases. Low temperature separation of the 
interconverting enantiomers of 
benzodiazepines 
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Benzodiazepines 
 
 
1.1 Introduction 
Most of commercially chiral drugs are either racemates or 
single enantiomers; the biological activity of chiral molecule 
differs from the racemate and the individual enantiomers, 
and it is well documented [1, 2]. 
Stereoisomers are isomeric molecules that have the same 
molecular formula and sequence of bonded atoms, but that 
differ only in the three-dimensional orientations of their 
atoms in the space. There is another, often overlooked, 
source of chirality: atropisomerism [3, 4]. Atropisomers are 
enantiomers or diastereoisomers resulting from slow axial 
rotation and that can interconvert thermally, slowly enough 
to allow analytical separation (~1000 s or longer). As bond 
rotation is time-depending, racemization for atropisomers 
can vary between minutes to years, depending on steric 
hindrance, electronic factors, temperature and solvents and 
has the potential to lead to sizeable pharmacological 
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consequence. Using quantum mechanics (QM), the 
calculation of energy barrier can predict atropisomerism. 
The increasing importance on atropisomers is due to their 
impact on pharmaceutical field to develop safe and stable 
substances that specifically target essential elements that 
cause disease. It is well-known the case of thalidomide, 
whose enantiomers differ dramatically and one is teratogen; 
the separation of each isomer in mixture is critical to assure 
the safety, quality and efficacy of drug [5, 6].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Correlation between calculated torsion rotation energy 
barriers, t1/2, and compound classes. 
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Atropisomers can be classified into three groups according 
to their time-dependent properties, based on rotational 
energy barriers, and this can suggest accompanying 
development strategies (Fig. 1) [7]. 
Class 1 are compounds that possess fast axial rotation rates 
on the order of seconds or faster, exhibit no axial chirality at 
room temperature, and have energy barriers to rotations 
(Erot)  of  < ~20 kcal/mol. These compounds do not have 
atropisomer properties.  
Compounds with Erot > ~20 kcal/mol can form 
atropisomers and can be divided into two classes, class 2 
and 3. Class 2 are compounds that present delayed axial 
interconversion with t1/2 values in the range of minutes, days 
or months. Class 3 compounds (Erot~30 kcal/mol) are 
those that experience very slow torsion-rotation rates (t1/2) 
on the order of years. These chiral compounds are stable 
over time and can thus be isolated as optically pure. 
Benzodiazepines, a well-known class of sedatives, 
hypnotics, anxiolytics and anticonvulsants, are a class of 
conformational enantiomers that present not only a single 
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bond rotation  but also a ―ring-flip‖ to switch from one 
enantiomer to the other. 1,4-benzodiazepines are 
characterized by a non-planar diazepine ring which inverts 
between two enantiomeric boat conformations [8]. The 
conformation of the diazepine ring presents four endocyclic 
torsion angles (2, 3, 4, and 5), but the two conformers 
are described by the sign of 3 (the angle defined by C(2), 
C(3), N(4), and C(5)), namely an (M)-conformer where 3 is 
negative, and a (P)-conformer where it is positive (Fig. 2) 
[9]. These two conformers differ in the orientation of the 
CH2 (3) group which lies above (M) or below (P) the plane 
defined by the fused benzene ring of the benzodiazepine.  
 
 
 
 
 
 
 
 
Figure 2: Diazepam enantiomeric conformers. 
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The two enantiomeric conformers of diazepam have the 
same conformational energy, the near-planar transition state 
is of ca. 17 kcal/mol above the low energy conformations, 
and its 3 and 4 assume synperiplanar geometries. The two  
conformers are in very rapid equilibrium and cannot be 
separated physically (Fig. 3).  
 
 
 
 
 
 
 
Figure 3: Enengy barrier of diazepam interconversion. 
 
 
The stability to racemization of these seven-membered ring 
systems depends on the bulkiness of the substituent attached 
to the amide nitrogen. Substitution around the (medium) 
rings must impose severe steric restrictions to bond rotation 
before these molecules become class 3 atropisomer. 
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N
N
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Cl
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1.2 Results and discussion 
 
1.2.1 Diazepam, prazepam, flunitrazepam and 
tetrazepam  
1.2.1 a Chromatographic resolution 
Diazepam and other glycine-derived 1,4-benzodiazepin-2-
ones are examples of drugs that existed as mixtures of chiral 
conformations, that are not separable at room temperature 
cause their barriers to interconversion are sufficiently low.   
These class of substances, lacking a chiral center, exist in 
the form of axially chiral enantiomers that usually show 
rapid interconversion due to facile ring flipping at room 
temperature. 
 
 
 
 
 
Figure 4: structure of 1,4-benzodiazepin-2-ones. 
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For BDZs unsubstituted at C3 (Ra=Re=H), such as 
diazepam (Fig. 5), the equilibrium in solution is extremely 
rapid, the calculated activation energy is ~ 17.6 kcal/mol 
(Fig. 3) [10].  
We focused our attention on four benzodiazepines (Fig. 2), 
very close, in term of structure, to diazepam to explore the 
influence on chromatographic separation and on 
enantiomerization barriers of substituent in N1. 
 
 
Figure 5: diazepam, flunitrazepam, prazepam and tetrazepam 
 
Flunitrazepam differs from diazepam for the presence of a 
fluorine group on the aryl ring and for a nitro group in 7 
position instead of chloride. Prazepam presents a 
ciclopropyl at the N1 and tetrazepam has a partially 
saturated, non planar ring in position 5.   
N
N
H3C
Cl
O
N
N
H3C
O2N
O
F
N
N
Cl
O
N
N
H3C
Cl
O
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The chromatographic separations were performed on a CSP,  
we selected Whelk-O1 for its extraordinary degree of 
generality. The Whelk-O1 CSP is based on 1-(3,5-
dinitrobenzamido)-1,2,3,4,-tetrahydrophenanthrene, this π-
electron acceptor/π-electron donor phase allows the 
resolution of a wide variety of underivatized racemates (see 
part A2 for the chemical structure). At room temperature the 
separation were unsuccessful for all of these drugs due to 
their rapid interconversion (explained before), they showed 
only one single peak. At sub-ambient temperatures, high 
values of enantioselectivity and resolution factors were 
obtained using  hexane-CH2Cl2-MeOH 60/60/1 mixture as 
eluent, delivered at a flow rate of 1.0 ml/min. At -20 °C the 
chromatographic profile of diazepam shows two distinct 
peaks separated by a plateau, the on-column 
enantiomerization process is slower than the 
chromatographic resolution (Fig. 5). The on-column M/P 
interconversion process results completely locked at -66 °C. 
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Figure 5: diazepam, column (R,R)-Whelk-O1, eluent 
hexane/CH2Cl2/MeOH 60/60/1, flow rate 1 ml/min, UV detection at 280 
nm. 
 
Flunitrazepam presents a nitro group instead of the chlorine 
atom and also presents a fluorine on the non-fused phenyl 
ring, these differences in the structure influence both the 
separation and the interconversion. At -32 °C the two 
enantiomers were still not resolved, we observed two 
distinct peaks at -55 °C with a plateau and the process was 
completed locked at T lower than -62 °C. 
0 5 10 15 20 25 30
T °C
23
-20
-28
-35
-66
time (min)
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0 5 10 15 20 25 30
T °C
23
-20
-32
-55
-66
time (min)
 
 
 
 
 
 
 
 
Figure 6: flunitrazepam, column (R,R)-Whelk-O1, eluent 
hexane/CH2Cl2/MeOH 60/60/1, flow rate 1 ml/min, UV detection at 280 
nm. 
 
Prazepam presents exactly the same structure of diazepam 
except for the substituent in N1, it presents a cyclopropyl 
methyl, a larger group than the methyl group. 
In this case and also in the case of tetrazepam, the plateau is 
visible already at -11 °C and the interconversion is locked at 
-35 °C in the case of prazepam (Fig. 7), and at -66 °C in the 
case of tetrazepam (Fig. 7). 
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Figure 7: prazepam (top), tetrazepam (bottom) column (R,R)-Whelk-
O1, eluent hexane/CH2Cl2/MeOH 60/60/1, flow rate 1 ml/min, UV 
detection at 280 nm. 
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1.2.1 b Simulation of  dynamic chromatograms 
The enantiomerization barriers of diazepam, tetrazepam, 
funitrazepam and prazepam have been determined by 
dynamic HPLC on the Whelk-O1 CSP. Interconversion 
profiles featuring plateau formation and peak broadening 
were observed and simulated by the lab-made computer  
program  Auto DHPLC y2k based on the theoretical plate as 
well as on the stochastic model using the experimental data 
plateau height. Dynamic deformations of the experimental 
chromatograms were exploited to extract kinetic data 
pertinent to the enantiomerization process occurring during 
the chromatographic runs.  
Program  Auto DHPLC  y2k  [11] implements  both 
stochastic  and theoretical plate models according to 
mathematical equations and procedures described  within  
ref.  [11a,b],  respectively. Figure 8 shows all the 
chromatographic profile, both experimental (black) and 
simulated (red).  
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 time (min)
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time (min)
5 10
 time (min)
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: experimental (black) and simulated (red) profile of diazepam 
at -28 °C (top, left panel); flunitrazepam at -66 °C (top, right panel); 
prazepam at -20 °C (bottom, left panel) and tetrazepam -20 °C (bottom, 
right panel). 
 
As shown in Tab 1 the stability towards racemization of 
these seven-membered ring systems depends on the 
bulkiness of the substituent attached to the N1 amide 
nitrogen. When observing the energy barriers listed in table 
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1, the lower values Gǂ12 are the ones related to the 
conversion of the first eluted enantiomer into the second 
one, and are those closer to values recorded by other 
techniques in free solution (e.g. by D-NMR) in the absence 
of the usually retarding effect of the stationary phase. The 
calculated activation energy of diazepam is G12 =17.60 
kcal/mol ± 0.02 (in agreement with D-NMR literature data). 
A similar value is observed for tetrazepam, a result that is 
consistent with the energy barrier depending on the size of 
the N1 substituent. For prazepam, that has the largest group 
on N1, the energy barrier is significantly larger, around 
18.65 kcal/mol. Flunitrazepam, on the other hand, has a 
lower barrier for the M/P interconversion: the presence of 
the two electron-withdrawing nitro and fluorine substituents 
on the two phenyl rings presumably decreases the electron 
density on the diazepine ring and facilitates the ring 
inversion process.  
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Table 1: Enantiomerization barriers (in kcal/mol) obtained by D-HPLC. 
T = column temperature within 0.1 °C. Errors in Gǂ ± 0.02 kcal/mol. 
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1.2.1 c 
1
H-NMR and D-NMR of flunitrazepam 
The 
1
H-NMR spectrum (400 MHz, CDCl3, 25 °C, TMS as 
external standard) of flunitrazepam showed a singlet at 3.5 
ppm due to the methyl group, two distinct signal at 3.8 and 
5.0 ppm corresponding to the two methylenic protons Ha 
and He, (J= 11.5 Hz) (Fig. 9). Downfield between 7.0 and 
8.5 ppm a complex absorption pattern is observed, 
corresponding to the aromatic proton resonances.  
The enantiomerization barrier of flunitrazepam was 
monitored also by variable-temperature NMR spectroscopy 
(dynamic NMR), because its enantiomerization barrier, 
previously calculated by D-HPLC, is so low in the NMR 
time scale to permit to see the exchange at value of T close 
to ambient temperature. 
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Figure 9: 
1
H-NMR spectrum of flunitrazepam in CDCl3. 
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The experiments of dynamic NMR where carried out in two 
different solvent, CD3OD and d6-DSMO, to evaluate also 
the influence of the solvent on the enantiomerization barrier. 
The experiments were performed in a temperature range 
between 27.5 and 92 °C in d6-DMSO and 27.5 and 72.6 °C 
in the case of CD3OD (Fig. 10). At room temperature, for 
both the experiments, the methylenic protons of C3 gave 
two distinct peaks. When the temperature is raised above 
27.5 °C, the rotation becomes faster and the M enantiomer 
into the P interconversion becomes increasingly faster on 
the NMR time scale. At the highest temperature the 
interconversion is so fast that the two protons are no longer 
diastereotopic and coalesce into a single averaged signal. 
Increasing the temperature didn‘t change all the spectrum  
but only the signals of methylenic protons. As the 
temperature is raised, the signals become first two broad 
signals and then they turn into a single signal (Fig. 10). The 
coalescence temperature observed for the experiments in 
DMSO was 64.9 °C and 72.6 °C for CD3OD. The free 
activation energy was calculated according to the following 
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equation (derived from the Eyring equation k=(kBT/h)e
-
ΔGǂ/RT 
): 
 
ΔGǂ = 4.58*Tc*[10.32 + log (Tc/kc)] 
 
where Tc is the coalescence temperature and kc is the kinetic 
constant of the interconversion process at coalescence 
temperature : 
kc = 2.22*[(
 + 6(JAB)
2 ]1/2 
wherezis the frequency difference between the two 
signals in the absence of exchange, JAB is the J-coupling 
between A and B also in absence of exchange.  
The ΔGǂ was 15.72 ± 0.01 kcal/mol at Tc= 64.9 °C in d6-
DMSO and 16.01 ± 0.01 kcal/mol at Tc= 72.60 °C in 
CD3OD, in agreement with the values previous determined 
by D-HPLC (15.61 ± 0.02 kcal/mol). As expected, the 
barriers of interconversion are unaffected by the nature of 
the solvent, as is usually the case for thermal 
enantiomerization processes occurring by conformational 
changes.   
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Figure 10 : flunitrazepam, DNMR, top DMSO, bottom CD3OD. 
27.5  C
40.4  C
53.3  C
59.7  C
62.3  C
63.3  C
64.9  C
66.2  C
79 C
91.9  C
A-1 
 
34                                   Ph. D. Thesis 
 
1.2.1 d diazepam ring-opening 
 
The diazepine seven-membered ring in BDZ is known to be 
highly sensitivity to hydrolysis in both acidic and basic 
media. The ring opening can occur by initial breakage of the 
amide functionality or the C—N bond, in both cases the 
final product being the substituted 2-aminobenzophenone. 
Gallardo Cabrera at all in their studies showed that, in 
addition to the expected 2-methylamino-5-
chlorobenzophenone, other products were formed [12] when 
the experiments were carried out with HCl in aqueous 
MeOH media. 
Our study on the seven-membered ring opening showed the 
breakage of the C-N bond, without employing acid or basic 
media. Dynamic chromatographic runs performed on a  
column of cyclodextrin and H2O/MeOH/AcONH4 (80/20; 
20 mM)  mixture as eluent at pH 3.5, showed two distinct 
peaks in a ratio of 95:5 whose signals are connected by an 
asymmetric plateau (Fig. 11) visible at T greater than 50 °C.  
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Figure 11: diazepam, column ACC-1-23, eluent H2O/MeOH/AcONH4 
80/20 20 mM pH=3.56, flow rate 1 ml/min, UV detection at 254 nm. 
 
 
By using high resolution MS we assigned the exact 
structures of the species corresponding to these two peaks. 
Direct electrospray of a solution of diazepam in MeOH/H2O 
(1:1) showed two signal: one at m/z 285.07 corresponding to 
the protonated diazepam and the other at m/z 303.08 
corresponding to the open ring (Fig. 12-13) form derived 
from the attack of one water molecule on the imine carbon 
C5. High resolution ESI_MS obtained on an orbitrap 
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instrument gave for the same two peaks the values of m/z = 
285.0773 (calculated for C16H14ClN2O
+
, m/z = 285.0789 ) 
and m/z = 303.0895 (calculated for C16H16ClN2O2
+
, m/z = 
303.0895), thus confirming the assignment. 
 
 
 
 
 
 
Figure 12: diazepam ring-opening. 
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Figure 13: HR-ESI-MS of diazepam. 
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1.2.2 Midazolam, triazolam, alprazolam and estazolam 
1.2.2 a Chromatographic resolution 
These BDZ present a pentatomic ring fused on the N1-C2 
bond of the diazepine ring: an imidazole, in the case of 
midazolam, and a triazole, in the other structures. These 
additional fused rings introduce another element of 
influence on the energy barrier ΔGǂ for the M/P 
interconversion.  
 
 
 
 
 
 
 
Figure 14: midazolam, triazolam, alprazolam and estazolam 
 
As for the other BDZs investigated before, these class are 
chiral even if they lack a chiral center and their enantiomers 
cannot be isolated at room temperature. Their 
chromatographic behavior was studied by dynamic HPLC in 
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the form of variable temperature.  The enantiomers of 
midazolam were resolved by HPLC on two columns: 
Chiralpak AD using hexane/isopropanol (70 : 30) as eluent 
and Chiralpak IA using hexane/CH2Cl2/MeOH  55/44/1. At 
6 °C, in both the experiments, the enantiomerization is 
completed locked and the two peaks corresponding to the 
M/P enantiomers are completely resolved at the baseline. 
Due to the long runs (40 min for Chiralpak AD and ~30 min 
with Chiralpak IA) the second peak is broad but its area is 
the same as that of the first eluted enantiomer. 
 
 
 
 
 
 
 
 
 
Figure 15: midazolam; left panel: Chiralpak AD, eluent hexane/IPA 
70/30, flow rate 1 ml/min, UV detection at 280 nm; right panel: 
Chiralpak IA, eluent hexane/CH2Cl2/MeOH  55/44/1, flow rate 1 
ml/min, UV detection at 265 nm. 
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Chiralpak AD afforded a good separation and resolution of 
the two enantiomers but long run time, so alprazolam and 
triazolam were only studied on Chiralpak IA.  
Alprazolam differs from triazolam for the absence of 
chlorine group on the aryl ring. The electron-withdrawing 
behavior of this group influences the interconversion barrier 
of the BDZ that requires lower T to be separated, in analogy 
to the conformational behavior of flunitrazepam (Fig. 16). 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: alprazolam (left panel), triazolam (right panel) column 
Chiralpak IA, eluent hexane/CH2Cl2/MeOH 55/44/1, flow rate 1 ml/min, 
UV detection at 265 nm. 
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1.2.2 b Simulation of  dynamic chromatograms 
Computer simulations (Fig. 17) of the chromatographic 
profiles yielded the isomerization barriers Gǂ= 20.54 ± 0.02 
kcal/mol for midazolam, 19.72 ± 0.02 kcal/mol for 
alprazolam and 17.33 ± 0.02 kcal/mol for triazolam. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: experimental (black traces) and simulated (red traces) 
HPLC plots. Top: midazolam Chiralpak IA, T 15 °C (right panel); 
Chiralpak AD, T 21 °C (left panel); Bottom: alprazolam T 0 °C; 
triazolam, T -25 °C. 
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 compound T k
a
1 
(min
-1
) 
k
a
-1 
(min
-1
) 
∆Gǂ12 
(kcal/mol) 
∆Gǂ21 
(kcal/mol) 
°C K 
midazolam AD 
 
16 289 0.246 0.046 20.07 21.02 
21 294 0.363 0.075 20.19 21.11 
midazolam IA 15 288 0.180 0.057 20.17 20.83 
 
alprazolam 
0 266 0.063 0.050 19.66 19.79 
-7 253 0.040 0.030 19.39 19.53 
-10 263 0.023 0.018 19.46 19.59 
triazolam -26 247 0.106 0.059 17.49 17.77 
Midazolam presents the largest Gǂ value, and the measured 
barrier is independent on the structure of the CSP (cfr IA vs 
AD columns). Midazolam has an imidazole ring fused on 
the diazepine ring and, in spite of the presence of the 
electron withdrawing fluorine on the C5 phenyl ring, it 
shows the highest energy barrier, indicating the imidazole 
ring renders the 1,4-diazepine more rigid compared to the 
triazole ring. When alprazolam and triazolam are compared, 
the lower barrier of the latter can be ascribed to the 
additional chlorine atom in the C5 phenyl ring of triazolam. 
 
 
 
 
 
 
 
 
 
 
Table 2: Enantiomerization barriers (in kcal/mol) obtained by D-HPLC. 
T = column temperature within 0.1 °C. Errors in Gǂ ± 0.02 kcal/mol.  
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1.2.2 c Reverse-phase chromatography of midazolam 
Human serum albumin (HSA) is an abundant plasma protein 
that binds a remarkably wide range of drugs, thereby 
restricting their free, active concentrations. The fundamental 
role of human serum albumin is as carrier for a variety of 
endogenous and exogenous compounds in serum [13]. 
It is well known that the activity of benzodiazepines 
depends on their binding with HSA, which has a specific, 
high-affinity BDZ binding site and shows a stereospecificity 
of binding [14, 18], it has been demonstrated that serum 
albumin shows a preferential affinity for the (M)-conformer 
of diazepam [9]. 
The binding properties of HSA can change in pathological 
conditions either because of its concentration or because of 
the concentration of endogenous compounds that selectively 
bind to the carrier. The investigation of the physiological 
role of albumin in the human body, the pharmacological 
consequences of drug-albumin binding  and the structure 
and the properties of the protein binding sites provides new 
insights into the  architecture and specificity of each drug 
A-1 
 
44                                   Ph. D. Thesis 
 
pocket on HSA and it is important to understand the 
molecular basis of the adaptability of this transporter 
protein.   
We investigated the conformation selectivity in the binding 
of midazolam to human serum albumin through dynamic 
HPLC and induced circular dichroism (ICD). Dynamic 
chromatographic experiments were carried out on a 
Chiralpak HSA, where human serum albumin is a selector 
immobilized on the silica, with an aqueous mobile phase 
containing a phosphate buffer at different pH.  This type of 
stationary phase is sensitive to the composition of the 
mobile phase, temperature, flow rate, and pH [19]. Different 
pH were used to modify the retention time and also the peak 
shape. Increasing of pH, increase the retention times and the 
selectivity. Dynamic HPLC were performed in a range of T 
between 10 and 25 °C (Fig. 18). 
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Figure 18: midazolam, column Chiralpak HSA, eluent phosphate buffer 
(0.1 M) 1-propanol 10% (pH 5.77 top left panel; pH 6.22 top right 
panel; pH 7 bottom); UV detection at 265 nm; flow rate  0.9 ml/min. 
 
 
The best separation was obtained at pH 6.22 or higher.  pH 
played an important role on the conformation of the HSA,  
changes in pH can produce structural transitions of the  
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protein, changes  in  the properties  of a  small molecule-
protein complex and can  produce  alterations  of the  degree  
of ionization  of the  ligand  molecule.  
Computer simulation of elution profiles, that originate from 
simultaneous separation and interconversion of enantiomers 
during liquid chromatography, were used to determine rate 
constants and activation parameters of the isomerization in 
reverse phase. 
 
  
 
 
 
 
 
Figure 19: experimental (black traces) and simulated (red traces) HPLC 
plots of midazolam at pH 6.2 (left panel) and pH 7 (right panel). 
 
 
Simulation of  the experimental chromatographic profile 
(Fig. 19) showed and confirmed that the enantiomerization 
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barriers are not affected by the solvent, temperature and pH. 
∆Gǂ was 20.77 ± 0.2 kcal/mol at pH 7 and T 9 °C, 20.54 ± 
0.2 kcal/mol at pH 6.22, T 15 °C. The energy barrier for 
enantiomer interconversion, ∆Gǂ, was between 20.19 and 
20.87 ± 0.2 kcal/mol in organic solvents (measured by 
DHPLC on chiral stationary phases under normal phase 
elution mode, see table 2) and similar values were obtained 
in aqueous media (20.55-20.99 ± 0.2 kcal/mol, table 3).   
 
 
 
Table 3: Enantiomerization barriers (in kcal/mol) obtained by D-HPLC 
under normal phase and reversed phase elution conditions. T = column 
temperature within 0.1 °C. Errors in Gǂ ± 0.02 kcal/mol.   
Column T  C ΔG1-2 ΔG2-1
Chiralpak AD
Normal phase
21 20.19 21.11
Chiralpak IA
Normal phase
15 20.22 20.87
Chiralpak HSA
Reverse phase
9 20.55 20.99
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When the HPLC separation of midazolam on the HSA 
column was monitored by CD detection at 265 nm,  the plot 
showed (Fig. 20) a positive signal for the first eluted 
enantiomer  and a negative signal for the second one at 265 
nm.  
 
 
 
 
 
 
 
 
Figure 20: UV (blue line) and CD (black line) recorded at 265 nm. 
 
 
Induced Circular Dichroism (ICD) spectrum detected for the 
interaction of midazolam with HSA is shown in Figure 21. 
The presence of HSA induces a CD positive signal in the 
region around 265 nm, and a negative band around 300 nm, 
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corresponding to the M chiral conformation for all the 1,4-
benzodiazepines studied so far.  
 
 
Figure 21: CD spectrum of a mixture of HSA (3·10
-5
 M) and 
midazolam (3·10
-3
 M) in phosphate buffer at room temperature. 
 
This ICD has been interpreted as originating from an 
imbalance of the original 1:1 M:P ratio, induced by the HSA 
binding of the interconverting enantiomers of the 
benzodiazepine, and favoring the M conformation. The 
HPLC results collected on the surface immobilized HSA, 
however, shows an opposite preference for the enantiomers 
of midazolam, whose second eluted enantiomer (the one 
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showing greater affinity for the immobilized HSA) has a 
negative CD sign when monitored at 265 nm (P chiral 
conformation). The same behavior was earlier reported for a 
tbutyl N1 substituted benzodiazepine, that showed ICD in 
the presence of HSA favoring the M conformation and 
HPLC resolution on immobilized HSA favoring the P 
conformation [20, 21].    
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1.2.2 d D-NMR of estazolam 
The interconversion between the enantiomers of estazolam 
is very fast at ambient temperature and the energy barrier 
was determined by DNMR. 
 
 
 
 
 
 
 
 
 
Figure 22: DMNR of estazolam in CD3OD. 
 
 
The energy barrier measured by D-NMR in CD3OD was 
14.54 kcal/mol. Attempted resolution of the interconverting 
enantiomers of estazolam by cryo-HPLC (down to -70 °C) 
on the Chiralpak IA column were unsuccessful: a single, 
broad unsplit peak was observed as a result of fast 
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interconversion on the time scale of the HPLC separation. 
The low M/P interconversion barrier in estazolam is easily  
explained by the absence of the methyl group on the carbon 
atom of the triazole ring. In the other there benzodiazepines 
midazolam, alprazolam and triazolam, the methyl group 
faces the H on the fused benzene ring,  and controls the 
rotational barrier of the  molecule (see figure 23 , where a 
biaryl type substructure has been highlighted). 
  
N
N
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N
N
Cl
H3C
H
 
Figure 23: general structure of benzodiazepines with pentatomic fused 
ring on the N1-C2 bond. Bold lines indicate the biaryl-type substructure. 
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1.2.3 Clobazam 
Clobazam, like the other benzodiazepines, lacks a chiral 
center and presents an additional carbonyl group on carbon 
C4 (Fig. 24). The additional carbonyl group is responsible of 
the conformational rigidity of the molecule and the stability 
of the two conformational enantiomers. 
 
 
 
 
 
 
 
 
Figure 24: structure of clobazam. 
 
The separation was performed on two different chiral 
columns Whelk-O1 and PhGlyDNB (N-3,5-dinitrobenzoyl- 
phenylglycine see part A2 for the chemical structure), using 
hexane/CH2Cl2/MeOH 60/60/1 as mobile phase. As shown 
in the left chromatogram of  Figure 24 the separation at 22 
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°C is faster than the enantiomerization and two peaks, 
corresponding to the two enantiomers, are visible. 
 
 
 
 
 
 
 
 
 
Figure 25: column (R,R)- Whelk-O1 (left), PhGly DNB (right), eluent 
hexane/CH2Cl2/MeOH 60/60/1, flow rate 1 ml/min, UV detection at 280 
nm. 
 
 
In the right figure the retention times are less than in the 
case of the Whelk-O1 and at 1 °C the enantiomerization 
process is completely locked and two peaks perfectly 
resolved at the baseline can be observed. At 37 °C the on-
column interconversion is faster than the separation and it is 
impossible to separate the two enantiomers. With PhGly-
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DNB it was possible to separate the two enantiomers in a 
range of temperature between 1 and 15 °C. Kinetic 
parameters for the on-column interconversion phenomena 
have been extracted from experimental peak profiles by 
computer simulation (Fig. 26). The corresponding averaged 
energy barrier  is equal to Gǂ = 21.07 ± 0.2 kcal/mol . 
 
 
 
 
 
 
 
Figure 26: experimental (black traces) and simulated (red traces) HPLC 
of clobazam on (R,R)-Whelk-O1. 
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1.3 Conclusions 
 
Dynamic HPLC on chiral stationary phases of the 
conformational enantiomers of several 1,4-
benzodiazepines is a powerful technique that can be 
used to study in detail the stereochemistry of this class 
of interesting molecules. The technique allows for: 1) 
the physical separation of the individual enantiomers 2) 
the measurement of the interconversion barrier by 
computer simulation of exchange-deformed HPLC 
plots 3) the study of the interaction between the 
interconverting enantiomers and the immobilized chiral 
selector on the stationary phase. 
The method is complementary to D-NMR in terms of 
time scale and temperature range available, as well as 
in terms of tolerance to different solvents (organic or 
aqueous).   
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1.4 Experimental section 
 
1.4.1 Chemicals and materials 
All solvents were purchased from Sigma Aldrich (St. Louis, 
MO, USA). 
Benzodiazepines were gently provided by ISS (Istituto 
Superiore di Sanità) and FIS (Fabbrica Italiana Sintetici) 
Prior to use, all mobile phases were filtered on Nucleopore  
0.4 µm.  
 
 
1.4.2 Dynamic HPLC  
1.4.2 a Chromatographic apparatus 
Analytical chromatography was performed on a HPLC 
system composed by a Waters (Waters Associates, Milford, 
MA, USA) 1525 pump, a Rheodyne model 7725 20 µl 
injector, and a variable wavelength Waters 2487 ultraviolet  
spectrophotometric detector; and on a HPLC system 
composed by Jasco (Tokyo, Japan) with an universal 
Rheodyne 20 µl injector, Jasco PU 980 e Jasco PU 1580 
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CO2 pumps, a Jasco UV 975 and a Jasco UV/CD 995 
detectors. 
HPLC runs were performed at flow rates of 1.0 ml/min and 
monitored by simultaneous UV and CD detections. Column 
temperature was maintained within -66 °C using a home 
made cooling device. Samples were dissolved in the eluent.  
 
1.4.2 b Simulation of dynamic chromatograms 
Simulation of variable temperature experimental 
chromatograms were performed by Auto DHPLC y2k (Auto 
Dynamic HPLC), that uses both stochastic and theoretical 
plates models. Both chromatographic and kinetic parameters 
can be automatically optimized by simplex algorithm until 
the best agreement between experimental and simulated 
dynamic chromatograms is obtained. All the simulations 
were performed with the stochastic model. 
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1.4.3 Dynamic NMR 
Dynamic NMR was performed on a Bruker 400 MHz with 
d6-DMSO and d4-MeOH as solvents and TMS as internal 
standard.  
 
1.4.5 Mass Spectrometry experiments 
The experiments were performed using an ion trap LCQ 
DECA XP Plus or an Orbitrap Exactive (Thermo Fisher), 
equipped with an ESI source. Operating conditions for the 
ESI source were as follows: spray voltage, 5.00 kV; 
capillary voltage, 27 V; heated capillary temperature, 210 
°C; tube lens offset voltage, 20 V; sheath gas (N2) flow rate, 
15 units (roughly 0.75 L/min). Methanolic/water solutions 
were infused via a syringe pump at a flow rate of 5 μL/min.  
 
1.4.6 Circular dichroism (CD) measurements 
CD spectra were recorded on a Jasco J-715 
spectropolarimeter at room temperature, in a rectangular cell 
with 10 mm pathlength. The spectra were accumulated three 
times with a bandwidth of 1.0 nm. ICD spectra were 
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obtained as the difference of spectra of ligand(s)–protein 
mixture and of protein solution alone and ellipticities were 
expressed in millidegrees. Ligands were added in small 
aliquots of 10
-5
 M ethanolic solutions to 2 ml protein 
solutions. 
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Tri-o-thymotide 
 
2.1 Introduction 
Tri-o-thymotide (TOT) is a 12-membered macrocyclic 
trilactone that adopts chiral conformations. The TOT 
molecule exists in solution as a rapidly equilibrating mixture 
of a time averaged pC3 propeller conformation (major) and a 
hC1 helical conformation (minor), as revealed by NMR 
spectroscopy (Fig. 1).  
O
O O
O
O
O
 
Figure 1 Structure of Tri-o-thymotide 
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The TOT molecule has been shown by NMR to exist in 
solution as a mixture of a major, propeller, conformation 
(approximate molecular symmetry C3-3) and a minor, 
helical conformation (C1-1), each of which is present in two 
enantiomeric forms. 
However, in its neat crystals and in its complexes it always 
has the shape of a somewhat flattened three-bladed 
propeller, with all three carbonyl oxygens on the same side 
of the mean ring plane. 
The major propeller species has all three carbonyl oxygen 
atoms pointing to the same side of the macrocyclic ring 
whereas the minor helical has only two carbonyl oxygen 
atoms pointing in the same direction [1]. The pure 
crystalline phase of TOT is a racemic mixture of the two 
enantiomers of the propeller conformation. 
The accepted interconversion scheme of TOT stereoisomers 
features a stepwise sequence from, for example, one 
enantiomer of the propeller conformation pC3 to one 
enantiomer of the helical conformation with one blade 
reversed hC1, then to the enantiomeric helix conformation 
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pC3       hC1      ent-hC1        ent-pC3→←→←→←
with two blades reversed ent-hC1 and finally to the 
enantiomeric ent-pC3 propeller conformation (eqn (1)). 
 
 (1) 
 
 
The propeller to helix switch and its reverse process have 
energy barriers of 21.4 ± 0.9 kcal/mol and 20.7 ± 0.9 
kcal/mol, respectively, as measured by D-NMR, while the 
barrier for the enantiomeric helix to helix exchange is 
unknown for TOT.  However, the same helix to helix 
process in two trilactones closely related to TOT was 
investigated by D-NMR and gave energy barriers of 14.3 ± 
0.5 kcal/mol for tris-3,6-dimethylsalicylide and 17.6 ± 0.2 
kcal/mol for tri-o-carvacrotide, suggesting a much faster 
process compared to the propeller to helix exchange [2]. In 
the solid state, neat TOT as well as TOT complexed with 
guests are always found in a flattened three-bladed propeller 
conformation with approximate C3 symmetry [1c].  
Upon cocrystallization with compounds with which it forms 
clathrate inclusion complexes, TOT often undergoes 
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spontaneous resolution. Any single crystal contains only P 
or only M TOT host molecule. The most common form of 
TOT clathrate crystallizes as discrete C2 symmetric cavities 
in the chiral space implying that the (-)-(M) and (+)-(P) 
forms separate spontaneously as crystallization occurs.  
Interest in the TOT molecule and in its complexation 
behavior is due to the ability of TOT to give spontaneous 
resolution when forming clathrate inclusion crystals with a 
large variety of guests. Besides intrinsic scientific interest in 
TOT clathrate formation and properties, several studies have 
addressed specific applications of TOT in separation 
science, solid state asymmetric reactions, determination of 
absolute configuration of chiral guests, non-linear optical 
properties and sensor devices [3]. 
While solution and especially solid state chemistry of TOT 
is rich and varied, its HPLC chromatographic behavior on 
chiral stationary phases is completely unexplored. The fast 
room temperature exchange of  TOT molecules between our 
populated species (the two enantiomers of the propeller and 
of the helix conformations) and the complex 
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chromatographic pattern expected under sub-ambient 
temperature condition shave certainly hampered progress in 
this field. 
Here are presented the results on the dynamic 
chromatographic behavior of TOT at sub-ambient 
temperatures on different chiral stationary phases (CSP1-3, 
see further for their chemical structures) together with a 
computational investigation of TOT molecular conformation 
and chiroptical properties that were used to assign the 
absolute configuration to the isolated enantiomers of pC3-
TOT. 
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2.2 Results and discussion 
 
Attempts to resolve the complex mixture of TOT 
stereoisomers by HPLC on CSPs at room temperature were 
unsuccessful. However, variable temperature HPLC runs on 
CSP1 showed temperature dependent chromatographic 
profiles that are indicative of on-column interconversion 
processes occurring on the same time scale of the separation 
process (Fig. 2, right panel) [4].  
The UV trace shows a single, coalesced peak at 26 °C that 
broadens at 21 °C and eventually splits partially into two 
unequally intense peaks at 15 °C. As the column 
temperature is gradually lowered, the separation between the 
two peaks increases while the first eluted peak shows a 
decoalescence process that culminates at -12 °C with the 
appearance of a third peak. At this temperature, the 
integrated peak areas are 10 : 45 : 45 from low to high 
retention times. 
Simultaneous CD monitoring (Fig. 2, left panel) of the 
dynamic behavior of TOT on CSP1 shows the absence of 
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signals at 26 °C and only two, equally intense, bisignated 
peaks at lower temperatures corresponding to the major 
peaks observed by UV detection. 
 
 
  
 
 
 
 
 
 
 
 
Figure 2: dynamic HPLC of TOT on (R,R)-CSP1, eluent 
hexane/CH2Cl2/2-propanol 40/40/10, flow rate 1 ml/min; UV (left panel) 
and CD (right panel) detections wavelength. 
 
 
 
The UV dynamic pattern clearly shows that the three species 
are mutually interconverted during HPLC at higher 
temperatures, and this was easily confirmed by cycles of 
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low temperature HPLC peak collection, room temperature 
equilibration followed by low temperature HPLC analysis of 
the equilibrated fractions: each of the isolated peaks gave, 
after thermal equilibration, the same original three peaks 
mixture. These preliminary results are fully consistent with 
the known solution interconversion scheme of TOT 
stereoisomers. Thus, the two major peaks observed at lower 
temperatures can be assigned to the two enantiomers of the 
propeller conformation, pC3 and ent-pC3, while the third 
minor peak can be assigned to the unresolved, rapidly 
interconverting enantiomers of the helical conformation hC1 
and ent-hC1. Attempted separations of these latter species by 
cryo-HPLC down to -78 °C (Fig. 3) on CSP1 were 
unsuccessful as a result of unfavorable changes of 
selectivity with temperature, leading to peak overlapping at 
low T.  
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Figure 3: variable temperature, column CSP1, eluent  hexane/CH2Cl2/2-
propanol 40/50/10, flow rate 1 ml/min; UV detection at 245 nm. Insets 
show the peaks overlapping of C1 and 1
st
 eluted C3 TOT. 
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CSP2 has no selectivity for the major, propeller pC3-TOT 
species and a low selectivity for the minor, helical hC1-TOT 
species that are marginally resolved. However, partial 
splitting of the minor peak was observed at -90 °C on CSP2, 
thus confirming the assignment and suggesting a much 
lower barrier to interconversion between the enantiomers of 
the TOT helical conformation (Fig. 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: two replicate overlaid HPLC runs at -90 °C, column CSP2, 
eluent hexane/CH2Cl2/2-propanol 40/50/10; flow rate 1 ml/min; UV 
detection at 245 nm. 
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Low temperature micropreparative HPLC runs on CSP1 
were also exploited to collect the individual enantiomers of 
the propeller conformation of  TOT.  
HPLC separation carried out with the column cooled at -10 
°C allowed us to process milligrams of TOT by iterative 
chromatography. Collected fractions of the pure individual 
enantiomers, pC3 and ent-pC3, were stored at low 
temperatures and used to acquire CD spectra of the 
enantiomers as well as to monitor the CD signal decay as a 
function of time (Fig. 5).  
 
 
 
 
 
    
 
 
 
Figure 5: decay of CD signal for the 2
nd
 eluted enantiomer as a function 
of time at T  0 °C. 
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The CD spectrum of the first eluted enantiomer from (R,R)-
CSP1 shows a positive band centered at 245 nm, which is 
mirrored in the CD spectrum of the second eluted 
enantiomer. With the isolated enantiomers of the propeller 
form in hand, their thermal racemization [5] was monitored 
by CD at 245 nm in a thermostatted cuvette. Conversion of 
one propeller enantiomer pC3 to the equilibrium mixture 
follows a first-order kinetic at T= 0 ± 0.1 °C in the HPLC 
eluent. From the linear logarithmic plot of CD signal vs. 
time, a first-order rate constant of 0.0385 min
-1 
was 
calculated, corresponding to a free energy barrier ΔGǂ = 
19.93 ± 0.02 kcal/mol.  This result is in good agreement 
with the values found by polarimetry at T = 23 °C in CHCl3 
(ΔGǂ= 20.3 ± 0.2 kcal/mol) and in benzene (ΔGǂ = 20.2 ± 0.2 
kcal/mol)[6]. We additionally used an independent HPLC 
approach to extract kinetic data for the propeller–helix 
interconversion process. When equilibrated solutions of 
TOT are analyzed by HPLC on the racemic version of CSP3 
(Fig. 6), only two unequally intense peaks corresponding to 
the helical (10.1%, minor, hC1 and ent-hC1 coeluted) and to 
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the propeller (89.9%, major, pC3 and ent-pC3 coeluted) 
species are observed under conditions of slow on-column 
interconversion.  
 
 
 
 
 
 
 
 
 
 
 
Figure 6: variable temperature HPLC of TOT on racemic CSP3. 
 
 
As the column temperature is raised, accelerated on-column 
interconversion generates a plateau between the two 
resolved peaks that eventually coalesce at higher 
temperatures into a single broad peak. Computer simulation 
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[4f] of the dynamic HPLC profile recorded with the column 
temperature set at 15 °C (Fig. 7) yields the apparent rate 
constants k1,2= 0.75 min
-1
 for the on-column helix to 
propeller conversion and k2,1= 0.08 min
-1
 for the reverse 
process. The associated energy barriers ΔGǂ1,2= 19.4 ± 0.1 
kcal/mol
 and ΔGǂ2,1= 20.6 ± 0.1 kcal/mol are consistent with 
the corresponding literature data and with the energy barrier 
measured here in the same solvent by off-column thermal 
equilibration of a single pC3 enantiomer. It has to be noted 
that the computer simulation of the on-column exchange 
process yields only the apparent kinetic constants, and these 
are to some extent potentially perturbed by the presence of 
the stationary phase. Nonetheless, the simulation correctly 
reproduces the expected difference in the energy barriers for 
the hC1 to pC3 conversion. 
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Figure 7: experimental (red) and computer (blue) simulated dynamic HPLC on 
racemic CSP3 thermostatted at T 15 °C (left panel) and at T -5 °C (right panel); 
eluent hexane/CH2Cl2/2-propanol 40/40/10, flow rate 1 ml/min, UV 250 nm. 1: 
helical C1-TOTconformer; 2: propeller C3-TOT conformer. 
 
 
To assign the absolute configuration to the 
chromatographically isolated enantiomers of pC3-TOT we 
used density functional theory (DFT) calculations of their 
Circular Dichroism (CD) spectra and compared them to 
those measured experimentally. The TOT molecule is 
conformationally flexible: the nonplanar 12-membered 
trilactone ring can adopt several conformations and the 
mutual orientation of the three phenyl rings varies easily as 
well. Since the measurements of the CD spectra have been 
carried out at 0 °C, a calculation of  the structures and 
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percentage distribution of the populated conformations of 
C3-TOT at that temperature is a prerequisite to the CD 
calculation. Structure of a TOT molecule was modelled in 
three steps: (1) exhaustive conformational search performed 
through stochastic Monte Carlo algorithm (for details see 
the Experimental Section), basing the structure optimization 
on MM2* molecular mechanics calculations in vacuum; (2) 
ranking of the obtained conformations according to their 
Boltzmann Populations (BP), and grouping into two 
ensembles on the basis of the orientation of the three 
carbonyl oxygen atoms with respect to the middle plane of 
the twelve membered macrocycle, limiting the choice to 
those structures found within an energy window of 5 kcal/ 
mol from the global minimum, (3) further optimization of 
the most stable conformation found in each of the two 
ensembles through DFT calculations (BLYP method with 
the QZ4P large core basis set), including dichloromethane 
solvent in the simulation. Step 2 gave a first ensemble 
consisting of propeller like conformations of C3 symmetry 
with the three carbonyl oxygen atoms pointing in the same 
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direction (97.2% BP at 0 °C) and a second ensemble 
including helical like conformations of C1 symmetry with 
only two carbonyl oxygen atoms paired (2.8% BP at 0 °C). 
Reoptimization with DFT in step 3 led to two unique 
structures (Fig. 8) with C3 (499.9% BP at 0 °C) and C1 
symmetry (< 0.1% BP at 0 °C).  At the same level of DFT 
theory, the C3 symmetry structure with M helicity has been 
submitted to simulation of the CD spectrum. Comparison of 
the DFT CD spectrum calculated for M-pC3-TOT to the CD 
traces registered for the enantiomers of pC3-TOT isolated by 
HPLC on CSP1shows that the first eluted enantiomer with a 
negative CD band at 245 nm has the M propeller 
configuration (Fig. 9) [7].  
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Figure 8: low energy structures of hC1 (left) and pC3 (right) TOT found 
by DFT optimization. Both are shown in the M configuration. 
 
 
Figure 9: experimental (red line, first eluted and blue line, second eluted) and 
DFT calculated (green line, M configuration) CD spectra of the enantiomers of 
propeller C3-TOT. Experimental spectra are recorded in the HPLC eluent at T 0 
°C. 
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2.3 Conclusions 
 
The dynamic HPLC behavior of TOT has been investigated 
in detail and the temperature regions where the TOT internal 
motions manifest themselves with exchange-deformed 
peaks have been identified. The absolute configuration of 
the C3 propeller enantiomers was assigned by comparison of 
DFT calculated and experimental CD spectra. 
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2.4 Experimental sections 
 
2.4.1 Low-Temperature Dynamic HPLC.  
Columns packed with CSPs 1-3 (Fig. 10) are available from 
Regis Technologies, Morton Groove, IL.  
Cryogenic HPLC was performed placing the column in a 
dry-ice/acetone or dry-ice/diethyl ether cooling bath, with a 
1 m long inlet capillary wrapped around the column to 
ensure thermal equilibration of the mobile phase. 
Temperatures were maintained within ± 0.5 °C for at least 
two consecutive, replicate analysis.  
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Figure 10: Structures of 
the chiral stationary 
phases CSP1-3. 
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2.4.2 Molecular Modeling Calculations.  
Conformational search of TOT was carried out by the 
Batchmin computer program, version 4.5 (Columbia 
University, NY), using the following options: MM2* Force 
Field, Monte Carlo stochastic algorithm with 5000 
generated structures, 100 most stable structures retained 
among all those obtained from the search, minimization by 
PR conjugate gradient. All the rotatable bonds resulting 
after temporary opening of the molecular cycle (eight 
torsional angles) were explored. The obtained geometries 
were analyzed by the home made computer program C.A.T. 
to exclude twin molecules and to make clusters based on 
energetic and geometric criteria. From this preliminary 
procedure fifteen geometries of TOT were obtained within 
an energetic window of 5 kcal/mol
 
from the global 
minimum. Seven among these conformers display very 
similar geometries of C3 symmetry, with all the carbonyls 
of the three ester groups placed at the same side of the 
macrocycle. The other eight conformers, also very similar 
one to each other, are asymmetric and display only two of 
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the three carbonyl groups at the same side of the 
macrocycle. The most stable conformers of each of these 
two ensembles have then been further optimized by DFT 
calculations based on the BLYP method with the QZ4P 
large core basis set, as implemented in the Amsterdam 
Density Functional (ADF) package v. 2007.01. Solvation 
energies in dichloromethane were also computed with the 
same program by the Conductor like Screening Model 
(COSMO), with the cavity defined according to the Solvent 
Excluding Surface (SES) algorithm. Finally, the CD 
spectrum of the M enantiomer of the C3 symmetry structure 
was calculated with the same method. The options were set 
at: single point calculation; 40 singlet and triplet excitations; 
diagonalization method: Davidson.  
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Enantioselective molecular recognition by 
mass spectrometry  
 
 
1.1 Introduction 
Molecular recognition is an important step in any chemical 
and biological processes, enzyme catalysis, cellular 
signaling, protein-protein association, protein crowding, 
reactant transport, to name a few. The non-covalent binding 
between a receptor and a ligand molecule involve the 
recognition between two or more molecular binding 
partners, leading either to their association or to their 
rejection. In chemistry, non-covalent interactions influence 
virtually every chemical reaction and the design of building 
blocks held together by non-covalent bonds refers to a 
particular field known as supramolecular chemistry [1, 3]. 
The examination and understanding of the non-covalent 
bond, is useful  to understand the action of biomolecules, to 
implement function into molecular devices such as sensors, 
to control mechanical movement, to passively and actively 
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transport molecules, and to use supramolecules as catalysts. 
The term molecular recognition refers to the specific 
interaction between a molecule (host) and another one 
(guest) through non-covalent bonding producing a new 
entity, defined complex or supramolecule, with properties 
different from those of each single component. 
The idea of coordination chemistry was formulated by 
Alfred Werner in 1893 [4], the lock-and-key concept was 
introduced by Emil Fischer in 1894 [5], and Villiers and 
Hebd discovered cyclodextrins, the first host molecules in 
1891 [6]. A few years later, Paul Ehrlich devised the 
concept of receptors in his studies on Immunity in 1906 [7] 
by stating that any molecule can have an effect on the 
human body only if it is bound (‗‗Corpora non agunt nisi 
fixata‘‘). Daniel Koshland formulated the induced fit 
concept (1958) for binding events to biomolecules which 
undergo conformational changes in the binding event.  
Generally the host appears as the largest component, such as 
an enzyme or synthetic cyclic compounds with a central 
hole or cavity, while the guest correspond to a small organic 
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or inorganic ion, or ion pair, or a little molecule with 
biological activity such as hormone or neurotransmitter. The  
host  is  defined  as  the  molecular  entity  possessing 
convergent  binding  sites  (e.g.  Lewis  basic  donor  atoms,  
hydrogen bond donors  etc.), while the guest is the entity 
possessing  divergent binding  sites  (e.g.  Lewis  acidic  
metal  cation  or  hydrogen  bond acceptor halide anion). In 
turn a binding site is defined as a region of the  host  or  
guest  capable  of  taking  part  in  a  non-covalent 
interaction [8]. The majority of work on this subject to date 
has focused on interactions in solution, where the results are 
strongly influenced by the presence of a solvent. However, 
more recently the study of supramolecular chemistry has 
taken to the electrospray ionization mass spectrometry, 
because is a ―soft‖ technique for the transfer of solution 
species into the gas phase. This is because the interactions 
are studied in the absence (or using small controlled 
amounts) of solvent and because of the intrinsic sensitivity, 
molecular specificity, and tolerance to impurities of the 
technique. Mass spectrometry, especially tandem mass 
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spectrometry, provides a unique method by which intrinsic 
interactions between molecules can be studied; information 
on the relative stabilities of non-covalent complexes is 
obtained from their gas-phase dissociation behavior. To 
achieve chiral recognition, multiple-point interactions (the 
―three-point rule‖) are required; this means that the chiral 
analyte and chiral reference need to be bound together in a 
polydentate complex, even if only transiently. 
Chiral recognition by MS is usually based on the 
measurement of following: (i) the relative abundance of 
non-covalent diastereomeric adducts between a chiral host 
and the two enantiomers of a guest; (ii) the relative stability 
of diastereomeric adducts by equilibrium measurements or 
by collision-induced dissociation (CID) experiments 
(Cooks‘ kinetic method) and (iii) the rates ion/molecule 
reactions between diastereomeric adducts and suitable chiral 
or achiral reactants [9, 10].  
 
Cooks’ kinetic method: the experiments were carried out by 
generating in the ESI source of an ion trap MS the proton-
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bound three-body complexes [M2·H·A]
+
, containing two 
molecules of the macrocycle M and one enantiomer of A, 
either A
R
 or A
S
. The homochiral [M
R
2·H·A
R
]
+
 and the 
heterochiral [M
R
2·H·A
S
]
+
 three-body complexes were 
individually subjected to collision-induced dissociation 
(CID) using He (10
-5 
Torr) as the target gas. The different 
CID fragmentation patterns reflect the relative stability of 
the diastereomeric adducts. The chiral resolution factor 
Rchiral corresponds to the Rhomo/Rhetero ratio (Rhomo= 
[M
R
·H·A
R
]
+
/[M
R
2·H]
+ 
; Rhetero= [M
R
·H·A
S
]+/[M
R
2·H]
+
) [11, 
13].  
 
50% Treshold method: the dimeric complexes [M·H·A]
+
, 
either homochiral and heterochiral, generating in the ESI 
source were isolated inside the ion trap and dissociated at a 
by collision with neutrals at variable energy. The 
enantioselectivity is expressed as the difference in the 
collision energy required to dissociate 50% of the parent 
diastereomeric [M·H·A]
+ 
complex (two experiments with 
enantiomeric guests) [14]. 
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Organic chemistry makes possible the construction of 
variable macrocyclic compounds. The most widely known 
macrocycles are crown ethers, cryptands, starands, 
cyclodextrins and calixarenes. In this work another group of 
synthetic receptors, macrocyclic amides, have been 
synthesized and their enantioselectivity have been 
investigated through mass spectrometry. 
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1.2 Results and Discussion 
1.2.1 Synthesis of macrocycles  
1.2.1 a Synthesis of A2B2 hosts 
Chiral receptors were prepared by a common 
macrocyclization reaction  of complementary A and B 
fragments to yield A2B2 macrocycles, where A are activated 
forms of isophthalic acid derivatives and B are chiral, C2 
symmetric (S,S)-1,2-diamines, derived from (R,R)-1,2-bis-
(2-hydroxyphenyl)-1,2-diaminoethane.  
The subunits A have been synthesized by transformation of 
the 5-hydroxy-isophthalic acid into the chloride of 5-
methoxy-isophthalic acid. We first carried out the protection 
of the carboxylic group by transformation in methyl ester 
through acetyl chloride in methanol heated at 50 °C. The 
reaction was monitored by TLC. The next step was the 
methylation of hydroxyl group. The suspension of 
compound 1 and potassium carbonate was stirred and heated 
at 80 °C for 1h under inert atmosphere and then dimethyl 
sulfate was added. The corresponding suspension was 
stirred and heated at 70 °C for 3h. After hydrolysis of the 
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ester groups, using KOH 5N in dioxane, we obtained as 
white solid 5-methoxy-isophthalic acid. The corresponding 
acid was quantitatively converted into the chloride 
derivative  by reaction with thionyl chloride (Scheme 1). 
 
COOHHOOC
OH
COOCH3H3COOC
OH
COOCH3H3COOC
OCH3
COOHHOOC
OCH3
a
b
c
d
COOClClOOC
OCH3
1
23
4  
 Scheme 1: (a) CH3OH, HClg, T 50 °C, 4h; (b) SO4(CH3)2, K2CO3, 
DMF; (c) KOH 5N, dioxane; (d) SOCl2  
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All subunits B were prepared by a 3,3-aza-Cope-
rearrangement described on JACS 2006, 130, 12184 [15]. 
Diaza-Cope rearrangement reaction can be used to 
synthesize meso-vicinal diamines by a unified approach for 
making enantiopure ―daughter‖ diamines from a single 
―mother‖ diamine (Scheme 2). 
 
NH2
NH2
OH
OH
1) 2.5 equiv
O
Ar
2) H2O
NH2
NH2
Ar
Ar
(R,R)-hpen (S,S)-3a to (S,S)-3e
 
 
Ar =
NO2 COOCH3
CN
OCH3 CN
3a 3b 3c 3d 3e
 
Scheme 2: synthesis of subunits B. 
Part B 
 
101                                   Ph. D. Thesis 
 
In a typical reaction, 2.5 equiv of an aldehyde is added to a 
solution of 1 dissolved in EtOH. The mother diamine 1 
reacts with the aldehydes to form the initial diimines 
(Scheme 3). In general the initial diimines are not isolated 
since they rearrange very quickly to the product diimines at 
ambient temperature (Scheme 3a). 
 
NH2
NH2
OH
OH
+
O
N
N
OH
OH
EtOH
NH3
+Cl-
NH3
+Cl-
HCl 37%
THF
R
R
R
R
R
1 2
3
 
 Scheme 3: Diaza-Cope rearrangement. 
N
N
OH
OH
N
N
OH
OH
R
R
R
R
Scheme 3a: Diimine rearrangement. 
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Once the rearrangement is complete, extraction was used to 
isolate the product diimine. The extract was dried and 
hydrolyzed (3% conc HCl in THF) without further 
purification to the diamine dihydrochloride salt as a white 
powder in good yields (90-99%). The diamine 
dihydrochloride salt can be converted to the neutral form by 
extraction under basic conditions. 
The macrocyclization reaction was carried out under very 
diluted condition of reaction (8 mM) between equimolar 
quantity of the two subunits (Scheme 4). The reaction was 
conducted in THF, in which both the subunits are soluble 
and in the presence of  the Huning‘s base using as scavenger 
for HCl. After the mixture was stirred for 12 h at room 
temperature, the solvent was removed at reduced pressure, 
the residue was dissolved in CH2CI2, and the organic 
solution was washed with 0.1 N HCl and brine, dried over 
Na2SO4, and after solvent removal, purified by column 
chromatography on silica gel. 
The diluted conditions are very important to obtain the 
cyclization and the ring closure and avoid the formation of 
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long linear chain, more polar, like –[X-Y]n–. The more polar 
oligomeric linear byproducts were easily removed by 
chromatography on silica gel. The dihedral angle N1-C1-C2-
N2 of the mother diamine and the orientation of the carboxy 
groups in the position 1-3 of subunits A are important 
structural parameter to obtain cyclic neutral products.  
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Scheme 4: macrocyclization reaction. 
 
 
NH2
NH2
Ar
Ar
+
OCH3
OO
Cl
HN
HNNH
NH
OCH3
OO
OCH3
O O
Cl
2. THF and 
DIPEA
1
R
RR
R
3a-3e
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(S)
(S)
N
N
H
H
N
N
(S)
(S)
OCH3
OO
OCH3
O O
H
H
R
R
R
R
4] A2B2 4d ; R = p-OCH3
1] A2B2 4a ; R = p-NO2
5] A2B2 4e  ; R = p-CN
3] A2B2 4c ; R = m-CN
2] A2B2 4b ; R = p-CO2CH3
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1.2.1 b Synthesis of A2B2T2A’2B2 
The A2B2T2A‘2B2 receptor was prepared via a click 
chemistry process, promoted by CuI, involving the dialkyne 
and diazide hosts derivatives to obtain the formation of 
cyclic compounds through molecular connections formed by 
an inter-intramolecular tandem process leading to discrete 
molecular receptors with only minor formation of the 
corresponding dimerization compounds. The azide-alkyne 
cycloaddition of bifunctional alkyne and azide monomers 
has proved to be a useful methodology for the formation of 
defined structures with 1,2,3-triazoles connecting units 
(Scheme 5). The reaction was carried out in toluene in 
presence of ([(EtO)3P CuI]) as catalyst and refluxed for 1h. 
After removing the solvent, the residue was purified by 
column chromatography to give a white solid. 
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OC2H4N3
HN
O
NH
O
OC2H4N3
NH
O
HN
O
O
OO
NH
O
O O
HN
HN
NH
NH
NH
HN
HN
O O
O O
O
NH
NH
HN
HN
O O
O O
O
O
N
NN
O
N
NN
+
(EtO)3P.CuI
DIPEA
 
 
Scheme 5: click chemistry process. 
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1.2.2 Spectroscopic characterization 
1
H-NMR spectra of receptors A2B2 type (A2B2 4a to 4e) 
show a reduced number of signal due to their C2 symmetry. 
As shown in Figure 1 there is one signal at 5.57 ppm for all 
protons of the stereogenic carbons and one signal for the 
protons of amides at different chemical shift for the different 
receptors. The equivalence is due to a rapid process of 
flipping of the structure.  
 
 
Figure 1: 
1
H-NMR spectrum of A2B2 4a  
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The number of signals is also reduced in the 
13
C-NMR 
spectra due to the C2 symmetry. In Fig. 2 there is only one 
signal at 167 ppm for carbonyl groups and at 60 ppm one 
signal for stereogenic carbons.  
 
 
Figure 2: 
13
C-NMR spectrum of A2B2 4a  
 
In the case of
 
A2B2T2A‘2B2, 
1
H-NMR spectrum shows four 
signals for the CO-NH- groups, two signals for each 
fragment A2B2, at 8.8, 8.75 and 8.68, 8.61 ppm (J=9.6 Hz; 
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7.2 Hz; 8 Hz; 8.8 Hz) because the structure is much more 
rigid for the presence of the triazole bridges, and the in-out 
flipping process is not observed. At 8.1 ppm the singlet 
signal corresponds to the protons in 2 of the isophthalic 
ring; the singlet signal at 7.78 ppm is the proton of the 
triazole ring. The presence of this only signal points out the 
possibility of only one regiochemistry of addition (Fig. 3). 
 
Figure 3: 
1
H-NMR spectrum of A2B2T2A‘2B2 
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Figure 4: circular dichroism spectra of the A2B2 receptors with B units 
having (S,S) configuration (A2B2 4a-e) or (R,R) configuration (RS04) 
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Y
1.2.2 Gas Phase Enantioselectivity 
1.2.2 a  CID of host/guest non-covalent complexes  
Macrocyclic amides are a group of synthetic receptors 
important for their amphipilic properties of their amido 
groups in dipolar or H-bonding interactions, the carbonyl 
acting as a dipole donor and a H-bond and the N-H as a 
dipole acceptor and H-bond donor [16, 18].  
Macrocyclic A2B2 tetramide receptors with polar groups on 
either A or B portions give weak signals for the proton 
bound species in positive ion mode. Intense signals are 
observed instead for the deprotonated species and for anion 
bound species in negative ion mode (Fig. 6). 
 
 
 
 
 
 
 Figure 6 
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In a typical ESI-MS spectrum we can observe three different 
signals corresponding to the dimeric complex [(M2) ·Cl]
-
 
generated by association, inside the ion trap, of two 
molecules of the complex in association with chloride ion, 
the signal [M · Cl]
-  
and the signal of the deprotonated host 
[M-H]
-
. There are two possible deprotonation sites. Due to 
the electron-withdrawing nature of the carbonyl group, the 
lone pair of electrons on the nitrogen is delocalized by 
resonance, as shown in Fig 6, so during the electrospray we 
could observe charged species obtained by the loss of a 
proton, generating a resonance stabilized anion with the 
negative charge on either the nitrogen or carbonyl oxygen of 
the amide fragment.   
Information about the relative stability of the homochiral 
and heterochiral [M-H·A]
-
 complexes has been derived from 
CID of the corresponding [M-H·A]
-
 adducts generated by 
electrospray ionization of M/A mixture; where M is a chiral 
host and A a chiral guest. The ability of our receptors to 
discriminate the enantiomers of a specific guest has been 
evaluated by isolating the dimers [M-H·A]
- 
inside the ion 
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trap followed by their dissociation by collision with neutrals 
(CID) at a different dissociation energy values. The lowest 
energy dissociation process involves the loss of the 
molecule of the guest, resulting in the free deprotonated 
hosts. In this way it was possible to monitor the decrease of 
the intensity of the dimeric complex and the increase of the 
[M-H]
-  
signal due to the dissociation of the dimeric 
complex. The enantioselectivity of the system is extracted 
based on the decrease of the signal intensity of the complex 
[M-H·A]
-  
as a function of the collision energy. We obtained 
two sigmoidal curves one for each complex and 
enantioselectivity is expressed as the difference in the 
collision energy required to dissociate 50% of the parent 
diastereomeric [M-H·A]
-
 complexes (Fig. 7). 
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Figure 7: threshold method showing the energy resolved dissociation 
curves for the two diastereomeric host-guest complexes formed by a 
single enantiomer of the host and the two enantiomers of the guest.  
 
The 1/2E  value for each complex was corrected for the 
degrees of freedom in the complex, relative to the 
deprotonated complex, chosen as a reference. 
   (1) 
 
 
 
 
(complex)] DOF  [#
)](reference DOF  [#(complex)]E [
=E
1/2
1/2
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1.2.2 b Applications 
The gas phase enantioselectivity was evaluated using 
different enantiomers of aminoacids as guests. We selected 
six amino acids with different molecular complexity to 
evaluate the influence of the structure on enantioselectivity 
(Fig. 8). 
 
 
Figure 8: structures of the aminoacid guest used in this study. 
 
 
The methodology employed was the 50% threshold, as 
explained before, the complex [M-H ·A]
- 
generated by 
electrospray of an equimolar mixture of host and guest (10
-4
 
M in acetonitrile) was isolated inside the ion trap. The 
energy dissociation values, necessary to dissociate the 
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complex, range from about 15% to 28% of the maximum 
CID voltage of 5 V. At the lowest CID energy value the 
100% of relative abundance corresponds to the intensity of 
the signal [M-H·A]
-  
that decrease with the increase of the 
dissociation energy. Figure 9 shows all the experiments 
carried out for all hosts with all guests. 
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Figure 9: dissociation curves for the dimeric complexes [M-H ·A]
- 
M: 
A2B2 hosts, A: amminoacids. Abbreviation within boxes: Ala: alanine, Val: 
valine, Leu: leucine, Ser: serine, Phe: phenylalanine, NaL: naphthylalanine.  
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Comparison of E1/2 values for complexes involving the same 
host but different aminoacids shows that overall stability of 
the complexes is governed by the size of the guest: with 
large guests the dissociation of the complexes is more 
difficult because the energy acquired by the charged host-
guest species by collision is distributed over a larger number 
of vibrational motions before culminating in the 
dissociation.  The more stable complexes are usually those 
formed with naphthylalanine as guest, requiring greater 
energy value to be dissociated, around 23%. By contrast, 
complexes with the smaller alanine guest require only needs 
21% of E1/2 . However, size of the guests is not the only 
factor governing the overall stability of the complexes, as 
the presence of aromatic units in the guests and the 
electronic nature of substituents on the A or B units both 
affect the stability of the complexes. 
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Figure 10: comparison of  E1/2 values for complexes involving the same 
host but different aminoacids (top) and the same aminoacid with 
different hosts (bottom).
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figure 10, bottom) and different A2B2 hosts are compared. 
Here the hosts with electron withdrawing p-NO2 and p-CN 
fragments on the phenyl rings of the B units have the lowest 
stability, and this is especially evident when compared with 
the p-OMe host: in spite of the similar size, the latter is 
much more stable than the other two, indicating either a 
beneficial effect of electron releasing groups on the stability 
or the presence of additional interaction sites stabilizing the 
complex. The host with the electron withdrawing p-COOMe 
fragments on the B units shows a mixed behavior: the host-
guest complex in this case is more stable compared to those 
formed by the hosts with p-NO2 and p-CN fragments and 
has a dissociation energy similar to that of the complex 
formed by the p-OMe host. In this case, the larger size and 
polarizability of the p-COOMe substituent together with its 
increased number of potential interaction sites, increase the 
stability of the host-guest system. 
Enantioselectivity in the host-guest systems follow a similar 
trend, and can be visually observed by considering the shift 
along the collision energy axis of the dissociation curves for 
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the two enantiomeric guests with the same host. The largest 
differences are observed for naphthylalanine when the same 
host is scrutinized towards several aminoacid guests, and 
with hosts carrying electron releasing groups on either A or 
B units when the same aminoacid guests is screened for 
enantioselectivity towards different hosts. With only few 
exceptions, the homochiral host-guest combinations are 
more stable than the heterochiral ones.  
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1.2.2 c A2B2-T2-A’2B2 
The recognition abilities of A2B2-T2-A‘2B2 have been 
explored by ESI-MS using a linear ion trap and by screening 
for selective association a collection of potential guests 
ranging from small sized aminoacids and peptides (Fig. 11) 
to large octahedral Ru(L3)
2+
 complexes (L = bpy, phen) 
(Fig. 12). In the first case it didn‘t show enantioselectivity, 
the complex host-guest was so weak that at 6% of collision 
energy the complex was not stable and in MS/MS spectrum 
was already visible the signal of the complex and of the 
host.  
 
 
 
 
 
 
 
Figure 11: dissociation curves for the complexes [M ·A]
2+
;
 
M: A2B2 
hosts, A: [Ru(Phen)3]
2+
.
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ESI of equimolar solution (10
-5
 M) of A2B2-T2-A‘2B2  and 
Δ- and Λ-[Ru(Phen)3]
2+ 
in acetonitrile gave intense signals 
for the doubly charged [host-guest]
2+
 complexes. [host- Δ -
guest]
2+
 and [host- Λ -guest]2+ were isolated inside the ion 
trap and dissociated at different values of collision energy. 
Energy resolved CID experiments for the two complexes 
yielded shifted dissociation curves, indicating 
enantioselective association in favor of Δ-[Ru(Phen)3]
2+
 
(Fig. 12). 
No enantioselectivity was observed for the same 
[Ru(Phen)3]
2+  
complexes with the
 
smaller A2B2 receptors. 
 
 
 
 
 
 
 
 
Figure 12: dissociation curves for the complexes [M ·A]
2+
;
 
M: A2B2-
T2-A‘2B2  hosts, A: [Ru(Phen)3]
2+
.
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1.3 Conclusions 
 
All these data suggest the enantioselective recognition 
originates from a blend of different interactions, including 
H-bonding and π-π aromatic stacking interactions, and is 
modulated by the functionalities present at the subunits A 
and B and by the bulkiness of the guests. 
The stability of the complexes increase as the size of guest 
and the number of degree of freedom increase as well. 
There is also a correlation between the complex stabilities 
and gas-phase basicity of the hosts. Hosts with a greater 
basicity show a greater stability in gas phase and require 
higher values of collision energy. 
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1.4 Experimental Section 
 
1.4.1 Chemicals and materials  
All solvents, samples, and reagents were ordered from 
Sigma-Aldrich (St. Louis, Mo, USA). Prior to use, THF was 
freshly purified from alumina. All anhydrous reactions were 
carried out under argon atmosphere. Analytical thin layer 
chromatography was performed on Merck F254 precoated 
silica (0.2 mm) on glass and was revealed by UV-light. All 
chromatography separations were performed with Merck 
Kiesegel 60 (0.040-0.063 mesh).  
 
 
1.4.2 Synthesis of chiral macrocyclic receptors 
a. Synthesis of subunit A 
A solution of 5-hydroxy-isophthalic acid (5 g, 0.027 mol) 
and acetyl chloride (5 ml) in 100 ml of MeOH was refluxed 
for 4 h, then the solvent was completely removed under 
reduced pressure recovering 4.2 g (0.021 mol yield = 96 %) 
of white powder consisting in pure 1. Metil estere of 5-
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hydroxy-isophthalic acid (2.5 g, 11.9 mmol) was added to a 
suspension of potassium carbonate (3.29 g, 23.8 mmol) in 
112 ml of acetonitrile with stir. The resulting solution was 
stirred for 30 min at 80 °C in inert atmosphere. After 30 min 
SO4(CH3)2 was added and the solution was stirred for 3h at 
70 °C. The mixture was neutralized with HCl 0.1 N and 
extracted with CHCl3 and washed three times with water 
(3x15 ml). The solvent was completely removed to give 
2.46 g of 2 (yield: 91.5%).  
An aqueous solution of  KOH 5N (75 ml) was added to a 
solution of 2 and stirred for 90 min at 70 °C. After 90 min, 
the solution was stirred over night at room temperature to 
give 1.96 g of 3 (yield 91%). A solution of 3 (0.35 g, 0.6 
mmol) in SOCl2 (8.15 g, 68 mmol) was refluxed and stirred 
for 4 h. After cooling to r.t., complete removal of SOCl2 
under reduced pressure afforded the compound 4 as a solid. 
The reaction is quantitative (Scheme 1).  
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b.  Preparation of C2 symmetric diamines by stereospecific 
Diaza-Cope Rearrangement (subunits B) 
B components were prepared by a 3,3-aza-Cope-
rearrangement of imines derived from substituted 
benzaldehydes and the chiral parent diamine 1,2-bis-(2-
hydroxyphenyl)-1,2-diaminoethane [JACS 2006, 130, 
12184].  To a cloudy solution of 1,2-bis(2-hydroxylphenyl)-
1,2-diaminoethane (1, 2.4 g 10 mmol) in 7.5 ml of methanol 
was added 25 mmol of aryl aldehyde. The resulting clear 
reaction mixture was stirred for 4h at room temperature to 
give  2 as a yellow precipitate. The solid was dried in 
vacuum (Scheme 3 in Results and discussion). To a solution 
of 2 in THF (2.5 ml) was added HCl (37%, 3 ml) and H2O 
(7,5 ml), the resulting solution was stirred for 5h at room 
temperature. The reaction was monitored by TLC, 
hexane/ethyl acetate 75/25 as eluent. 
After removal of the solvent under reduced pressure, the 
was treated with water and extracted with CH2Cl2; the 
aqueous layer was rendered basic with NaOH 12N until 
pH12, and extracted with CH2Cl2. The solvent was removed 
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under reduce pressure to afford analytically pure 3 (130 mg, 
0.43 mmol) as the free base. 
 
 
c. Synthesis of HOST A2B2 4a 
A2B2 4a was prepared by a general synthetic method in 
which the ethyl ester of 5-methoxy-ispophtalic acid in the 
minimum required amount of  THF (100 ml) was added 
dropwise to a tetrahydrofuranic solution of the 3a (130 mg, 
0.4 mmol) in DIPEA (0.15 ml, 0.8 mmol) with stirring. The 
resulting solution was stirred over night at room 
temperature. After complete removal of the solvent under 
reduced pressure the residue was treated with water and 
extracted with CH2Cl2. The organic layer was dried over 
anhydrous Na2SO4 and the solvent removed under reduced 
pressure. The solid residue was purified by column 
chromatography (SiO2, eluent: CHCl3/MeCN 70/30) to give 
84 mg (0.33 mmol, yield = 45 %) of pure 4a .  
MS (ESI) m/z: 959.3 [ (M · Cl)
-
] 
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1
H-NMR (CDCl3, 298 K) : δ 3.61 (s, 6H), 3.89 (s, 12H), 
5.57 (s, 4H), 7.26-7.90 (m, 20H ), 8.05 (s, broad, 4H) 
13
C-NMR (CDCl3, 298 K): δ 29.67,  52.19,  55.42, 60.30, 
97.68, 114.80, 116.79, 127.66, 129.96, 135.53, 142.71, 
159.93, 167.54, 168.04 
CD (nm) : (+) 232.05, (-) 210.43, (0) 220.87 
 
d. Synthesis of A2B2 4b-4e 
These complex were prepared according to the procedure 
described for A2B2 4a. 
 
A2B2 4b: 4b (270 mg, 0,82 mmol). Yield: 22% 
MS (ESI) m/z: 1011.4 [ (M · Cl)
-
]; 
1
H.NMR (CDCl3, 298 K) : δ 3.608 (s, 6H), 3.89 (s, 12H), 
5.57 (s, 4H), 7.26-7.90 (m, 20H ), 8.05 (s, broad, 4H). 
13
C-NMR (CDCl3, 298 K): δ 29.67,  52.19,  55.42, 60.30, 
97.68, 116.23, 118.79, 127.66, 129.96, 135.53, 142.71, 
159.93, 166.63, 168.04 
FT-IR (KBr): 3316, 2952, 1724, 1652, 1286, 1112, 709 cm
-1 
 
CD (nm) : (+) 232.05, (-) 210.43, (0) 220.87 
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A2B2 4c: 4c (220 mg, 0,84 mmol); Yield: 32%; 
MS (ESI) m/z: 867.9 [ (M · Na) 
+
], 1712.4 [ (M2 · Na)
+
]; 
1
H-NMR (DMSO-d6, 298 K): δ 3.80 (s, 6H), 5.59 (s, 4H), 
7.30-7.99 (m, 22H), 9.32 (s, broad, 4H) 
FT-IR (KBr): 3313, 3072, 2938, 2840, 2231, 1654, 1521, 
1054, 700 cm
-1
 
CD (nm) : (+) 240.71, (-) 212.47, (0) 230.53 
 
A2B2 4d: 4d (190 mg, 0,7 mmol); Yield: 26% 
MS (ESI) m/z: 887.42 [ (M · Na)
+ 
], 1752.17 [ (M2 · Na)
+
]; 
1
H-NMR (CDCl3, 298 K): δ 3.73 (s, 6H), 3.77 (s, 12H), 5.49 
(s, 4H), 7.26-6.77 (m, 20H), 7.97 (s, broad, 6H) 
13
C-NMR (CDCl3, 298 K): δ 55.18, 55.64, 60.80, 113.96, 
115.57, 118.13, 129.05, 130.67, 136.14, 159.05, 159.70, 
168.68 
FT-IR (KBr): 3309, 2998, 2937, 2836, 1648, 1513, 1249, 
833 cm
-1
 
CD (nm) : (+) 225.18, (-) 211.18, (0) 21 8.31 
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A2B2 4e: 4e (160 mg, 0,61 mmol); Yield: 30% 
MS (ESI) m/z: 843.5 [ (M - H) 
- 
], 879.3 [ (M · Cl)
- 
]; 
1
H-NMR (DMSO-d6, 298 K): δ 3.78 (s, 6H) 5.58 (s, 4H) 
7.94-7.26 (m, 22H) 9,39 (s, broad, 4H); 
13
C-NMR (DMSO-d6, 298 K): δ 56.01, 58.75, 71.86, 
110.72, 116.17, 118.55, 119.52, 129.56, 132.66, 136.70, 
144.83, 159.49, 167.45; 
FT-IR (KBr): 3307,  3068,  2938, 2840, 2229, 1662, 1525, 
1340, 838 cm
-1
; 
CD (nm) : (+) 228.00, (-) 205.84, (0) 219.58 
 
1.4.4 Synthesis of A2B2T2A’2B2 
A solution of 1 (0.130 g, 0.152 mmol), 2 (0.121 g, 0.152 
mmol), DIPEA (0.11 g, 0.85 mmol), and the copper catalyst 
[(EtO)3P•CuI] (0.013 g, 0.04 mmol) in toluene (65 ml) was 
refluxed for 1 h. Evaporation of the solvent yields a crude 
that was purified by column chromatography 
(CHCl3/isopropanol 50/25) giving 3 (0.03 g) yield= 15 % 
NMR, MS 
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1.4.5 
1
H, 
13
C-NMR Spectroscopy 
1
H and 
13
C spectra were recorded at 400 MHz on a Bruker 
400. CDCl3, CD3OD, CD3CN and (CD3)2SO were used as 
internal standard. 
 
1.4.6 IR and CD Spectroscopy 
Infrared (IR) spectra were recorded on    
Circular Dichroism (CD) spectra were obtained on Japan 
Spectroscopic J-710/720 polarimeter in acetonitrile (1 x 10
-5 
M). 
 
1.4.7 Mass Spectrometry experiments 
The experiments were performed using an ion trap LCQ 
DECA XP Plus (Thermo Finnigan), equipped with an ESI 
source. Operating conditions for the ESI source were as 
follows: spray voltage, 5.00 kV; capillary voltage, 27 V; 
heated capillary temperature, 210 °C; tube lens offset 
voltage, 20 V; sheath gas (N2) flow rate, 15 units (roughly 
0.75 L/min). Acetonitrile solutions are infused via a syringe 
pump at a flow rate of 5 μL/min.  
Part B 
 
135                                   Ph. D. Thesis 
 
ESI of solutions of the macrocyclic tetraamides M = A2B2 
4a, A2B2 4b, A2B2 4c, A2B2 4d and A2B2 4e (1 x 10
-4
 M) 
containing a three times amount of the aminoacid (1 x 10
-4
 
M), leads to the formation of appreciable amount of the 
corresponding [M-H•A]- and [(M)2-H•A]
-
 complexes. After 
individual isolation of the ions inside the ion trap, the 
isolated ions are subjected to a supplementary alternating 
current (AC) to excite them and cause fragmentation by 
collision with He gas (CID). Ion excitation time for CID is 
30 ms with the amplitude of the excitation AC being 
optimized in each experiment and being kept the same  for 
the measurement of the two enantiomeric guests with the 
same host. Optimized instrumental values of relative 
collision energy of 12-15% give exclusively the fragment 
ions of interest (relative collision energy values range 0-
100% corresponding to 0-5 V resonant excitation potential). 
Spectra acquired in the centroid mode are the average of 100 
scans, each consisting of three averaged microscans. 
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Absolute quantitation of human milk proteins and 
their glycoforms using MRM . 
 
 
1.1 Introduction 
Milk is the most important food for the newborn, due to its 
nutrient composition: immune components, anti-infective 
factors, and metabolic enzymes, which all contribute to the 
critical needs for growth and development during early life 
[1, 2]. Milk not only provide a digestible source of amino 
acids to infants, but it  also confer immunological 
protection, perform developmental and regulatory functions 
and some proteins play a role in facilitating the digestion 
and uptake of other nutrients in breast milk . Human milk 
proteins are particularly important for infants who are born 
prematurely,  it is well known that the protein composition 
of milk from preterm mothers is differ from that of term 
mothers. The protein content of human milk  changes during 
the lactation, it decreases rapidly during the first month and 
declines much more slowly after that.  
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Milk proteins can be classified into 3 groups: mucins, 
caseins, and whey proteins. Mucins, also known as milk fat 
globule membrane proteins, contribute only a small 
percentage of the total protein content of human milk. The 
fat content of human milk does not vary during the course of 
lactation so the milk mucin concentration is most likely 
constant. The contents of casein and whey proteins change 
profoundly early in lactation; the concentration of whey 
proteins is very high, whereas casein is virtually 
undetectable during the first days of lactation (Fig. 1) [3, 4]. 
Casein synthesis in the mammary gland and milk casein 
concentrations increase, whereas the concentration of total 
whey proteins decreases, partially because of an increased 
volume of milk being produced.  
 
 
 
 
 
 
 
 
 
Figure 1: Changes in whey 
protein (▲) and casein (■) 
concentrations during  
lactation in one mother. 
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The frequently cited ratio of 60:40 is an approximation of 
the ratio during the normal course of lactation, but it does 
vary from 80:20 in early lactation to 50:50 in late lactation 
[5, 8]. A comprehensive understanding of the human milk 
protein profile is important to understand not only milk 
biogenesis and functions provided to the newborn but also 
to develop infant formulas more similar in protein 
composition to human milk and to study some eventually 
problems in the absorption and digestions of milk proteins. 
Using gel electrophoretic method coupled with mass 
spectrometry less than 10 proteins were detected. More 
recently, proteomic studies employing strategies to deplete 
the high abundance proteins or  to fractionate the sample 
prior to analysis have been more successful at identifying 
low abundance proteins than the gel-based methods [9, 12]. 
Two studies in particular have identified a large number of 
low abundance human milk proteins. Palmer et al. used 
immunodepletion columns to deplete the five most abundant 
proteins in colostrum prior to 2D LC−MS/MS analysis and 
were able to identify 151 proteins. More recently, Liao et al. 
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[13] employed combinatorial hexapeptide ligand libraries 
(ProteoMiner) to enrich the low abundance milk proteins 
before analysis by LC−MS/MS and identified 115 proteins. 
Liao et al. also showed that many of these proteins change 
in expression over the course of 12 months of lactation, 
highlighting the dynamic nature of milk composition. The 
changes in milk proteins during lactation, however, have not 
been comprehensively examined, but quantifying these 
changes is very important to understand changes in cell state 
at a molecular level. 
Proteomic technologies based on mass spectrometry (MS) 
have emerged as preferred components for discovery of 
diagnostic, prognostic and therapeutic protein biomarkers 
[14, 17]. An important goal in proteomic is to quantify the 
profile changes of protein abundances in biological systems. 
The classical proteomic quantification methods utilizing 
dyes, fluorophores, or radioactivity have given very good 
sensitivity, linearity, and dynamic range, but they lack of 
two important shortcomings: first, they require high-
resolution protein separation typically provided by 2D gels, 
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which limits their applicability to abundant and soluble 
proteins; and second, they do not reveal the identity of the 
underlying protein. Both of these problems are surmount by 
modern LC-MS/MS techniques. However, mass 
spectrometry is not inherently quantitative because 
proteolytic peptides exhibit a wide range of 
physicochemical properties such as size, charge, 
hydrophobicity, etc. which lead to large differences in mass 
spectrometric response. One major approach is based on 
stable isotope dilution theory which states that a stable 
isotope-labeled peptide is chemically identical to its native 
counterpart and therefore the two peptides also behave 
identically during chromatographic and/or mass 
spectrometric analysis. A mass spectrometer can recognize 
the mass difference between the labeled and unlabeled 
forms of a peptide, quantification is reached by comparing 
their respective signal intensities. Stable isotope labeling 
was introduced into proteomics in 1999 by three 
independent laboratories [18, 21] and has since been 
adopted widely in the field. Isotope labels can be introduced 
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as an internal standard into amino acids (i) metabolically, 
(ii) chemically, or (iii) enzymatically or, alternatively, as an 
external standard using spiked synthetic peptides. More 
recently, alternative strategies—often referred to as label 
free quantification-have emerged [22].  
Label-free methods aim to compare two or more 
experiments by (i) comparing the direct mass spectrometric 
signal intensity for any given peptide or (ii) using the 
number of acquired spectra matching to a peptide/protein as 
an indicator for their respective amounts in a given sample. 
Proteomic studies are performed using a shotgun approach, 
in which the sample proteins are enzymatically degraded to 
peptides, which are analyzed by mass spectrometry using 
MRM (multiple reaction monitoring) [23].  
Multiple reaction monitoring (MRM) is a technology that is 
valued for its potential towards the reliable quantitation of 
analytes of low abundance in complex mixture. MRM is a 
non-scanning technique, generally performed on a triple 
quadrupole (QQQ) instruments in which the fragmentation 
is used to increase the selectivity. In MRM mode two mass 
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analyzers are used as static mass filters, to monitor a 
particular fragment ion of a selected precursor ion. The first 
and the third quadrupoles act as a filter to specifically select 
predefines m/z values corresponding to the peptide ion and a 
specific fragment ion of the peptide (transition), whereas the 
second quadrupole serves as collision cell. The precursor 
ion selected by the first mass filter (Q1) enters in the 
collision cell (Q2) where it undergoes collision induced 
dissociation (CID). One fragment ions is then selected by 
the second mass filter (Q3) (Fig. 2) [24, 26]. A high 
selectivity is obtained due to the two selection steps that 
filter out co-eluting background ions. In this way mass 
spectrometer monitors both the intact peptide mass and one 
or more specific fragment ions of that peptide over the 
course of an LC-MS experiment. The combination of 
retention time, peptide mass, and fragment mass eliminates 
ambiguities in peptide assignments and extends the 
quantification range to 4-5 orders of magnitude. MRM 
measurements are quantitative analyses strictly targeting a  
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predetermined set of peptides and depend on specific MRM 
transitions for each targeted peptide. 
 
 
 
Figure 2: SRM/MRM analysis on QQQ MS. 
 
Three types of information are necessary for a MRM 
project. First, the proteins that constitute the targeted protein 
set have to be selected. Second, for each targeted protein, it 
is necessary to identify peptides that present good MS 
responses and uniquely identify the targeted protein, or a 
specific isoform. Such peptides have been termed as 
proteotypic peptides (PTPs). Third, for each PTP, those 
fragment ions that provide optimal signal intensity and 
discriminate the targeted peptide from other species present 
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in the sample have to be identified. These optimized 
transitions are the essence of an MRM assay. 
The aim of this project was the quantitation of seven human 
milk proteins and their glycoforms using a label free method 
through multiple reaction monitoring.   
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1.4 Results and Discussion 
 
1.4.1 Method development 
1.4.1 b Proteins identification 
We selected seven proteins: lactoferrin, α-lactalbumin, IgG, 
s-IgA, IgM, α1-antitrypsin and lysozyme. 
Some proteins, such as bile salt–stimulated lipase, amylase, 
β-casein, lactoferrin, haptocorrin, and α1-antitrypsin, assist 
in the digestion and utilization of micronutrients and 
macronutrients from the milk. Several proteins with 
antimicrobial activity, such as immunoglobulins, lysozyme, 
lactoferrin, α-lactalbumin, and lactoperoxidase, are 
relatively resistant against proteolysis in the gastrointestinal 
tract and may contribute to the defense of breastfed infants 
against pathogenic bacteria and viruses [27]. 
Lactoferrin presents antimicrobial activities, it has a strong 
bactericidal activity against several pathogens.  
Lysozyme is one of the major components of the human 
milk whey fraction, it is capable of degrading the outer cell 
wall of gram positive bacteria. 
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α-lactalbumin binds Ca2+ and Zn2+ so it is possible that it has 
a positive effect on mineral absorption. 
α1-antitrypsin may limit the activity of pancreatic enzymes 
in breastfed infants, it also escape digestion in part and are 
found in the stool of breastfed infants. 
The major type of immunoglobulins in human milk is sIgA 
(> 90%)—a dimer of IgA linked together with a secretory 
component and a joining chain. This particular arrangement 
renders this molecule relatively resistant to intestinal 
proteolysis and modest amounts of sIgA have been found 
intact in the stool of breastfed infants. The immunoglobulins 
present antimicrobical activity. 
We chose these proteins either for their important functions 
and for their quantity. α-lactalbumin, secretory 
immunoglobulin A, lysozyme and lactoferrin constitute over 
90% of the total protein content in mature human milk [27, 
28] obscuring the detection of less abundant proteins of 
potential biological. Usually the concentrations in milk are: 
lactalbumin 3-6 mg/ml, lactoferrin 2-5 mg/ml, IgA 0.5-3 
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mg/ml, IgM 0.01-0.1 mg/ml, IgG 0.01-0.1 mg/ml, 
antitrypsin 0.05-0.3 mg/ml and lysozyme 0.1-0.3 mg/ml.  
 
 
1.4.1 a Trypsin digestion  
Trypsin digestion is necessary cause, for most mass 
spectrometers, proteins are too big to be analyzed by tandem 
MS. The samples were dissolved in ammonium bicarbonate 
(AmBic, 50 mM), in which all the samples are soluble and it 
doesn‘t influence the electrospray, and added DTT 
(dithiothreitol) in water bath at 50 °C for 60 min, 
denaturation and reduction  were carried out simultaneously 
by a combination of heat and a reagent.  DTT is a strong 
reducing agent, that reduce the disulfide bonds and prevent 
inter and intra-molecular disulfide formation between 
cysteines in the protein. By combining denaturation and 
reduction, renaturation of the proteins can be avoided. 
Following protein denaturation and reduction, alkylation of 
cysteine is necessary to further reduce the potential 
renaturation. The most commonly used agent for alkylation 
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of protein is iodoacetamide (IAA). Samples were alkylated 
with 50 mM iodoacetamide, 1h, at room temperature in 
dark. After that trypsin was added, it hydrolyzes only the 
peptide bonds in which the carbonyl group is followed 
either by an arginine (Arg) or lysine (Lys) residue, with the 
exception when Lys and Arg are N-linked to Aspartic acid 
(Asp). The cleavage will not occur if proline is positioned 
on the carboxyl side of Lys and Arg. Tryptic digestion is 
performed at an optimal pH in the range 7.5-8.5 and at 37 
°C for 18 h. Prior to LC-MS analysis, the resulting peptides 
were purified, to remove buffers and salts added during the 
sample preparation, by solid phase extraction (SPE) on a 
C18 column. The column were washed with 3 x 200 ml of 
water in 0.1% formic acid, 3 x 200 ml with acetonitrile in 
0.1% formic acid and 3 x 200 ml of water in 0.1% formic 
acid. Total volume of digest were loaded, wash with 3 x 200 
ml of water in 0.1% formic acid, and elute with 3 x 200 ml 
of 80% acetonitrile in 0.1% formic acid. Eluates were 
collected and dried in vacuum.  
 
Part C 
 
155                                   Ph. D. Thesis 
 
1.4.1 b Fragmentation of peptides and glycopeptides  
After complete removal solvent the resulting peptides and 
glycopeptides were reconstituted with water and analyzed 
using LC-Q-TOF MS/MS in order to obtain information 
regarding the amino acid sequence of the peptide and further 
used for protein identification or characterization. In order 
to select specific peptides representative for each proteins 
we used our MS/MS information with publicly accessible 
databases. Global Proteome Machine Proteomics Database 
[28] was utilized to choose the appropriate peptides based 
on the most abundant b and y-ions representing our seven 
target proteins. The collision energy used for the LC-Q-TOF 
MS/MS experiment was calculated on the basis of the m/z 
values of each fragment (eq.1, low energy).  
 
    CE (eV)= 1.8 m/z x 100 - 2.4                  eq (1) 
 
The CID fragmentation method can use two different type 
of energy: low- or high-energy. The low-energy CID allows 
the rearrangement of the peptide after the loss of a fragment 
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[30] and it allows for multiple collisions (up to 100) in a 
time scale for dissociation of up to milliseconds whereas, 
the high-energy CID does not permit such process as it is 
too fast, breaking the peptide. The low energy CID 
fragmentation method generates two type of daughter ions 
due to the break of the CO-N bonds along the peptide 
backbone: the b-series ions extend from the N-terminal and 
the y-series ions extend from the C-terminal (Fig. 3) [30].  
 
 
 
 
 
 
Figure 3: major fragment ions generated by CID of peptides. 
 
 
The calculation of the mass difference between consecutive 
daughter ions belonging to the same ion series (for example 
b  or  y  ion-series), allows the determination of peptide‘s 
primary sequence. CID fragmentation of peptides was 
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performed using helium, an inert gas, to hit the peptides 
resulting in the excitation of the molecular ion leading to the 
polypeptide chain breaking, and to a lower extent to that of 
the amino acid side chains, generating daughter ions. 
Fig. 4 shows the tandem mass spectra of two different 
peptides of lactoferrin.  These peptides generated mostly y 
and b-type ions. The CID (@23.7) of the peptide 1 of 
lactoferrin with a m/z values of 790.4 (doubly charge) gave 
different fragments, 228.1 b2, 341.2 b3, 488.3 b4, 749.4 y6, 
863.4 y7 1239.6 y10, to name a few.  The same experiment 
were carried out for all the standards and the resulting 
MS/MS data were submitted to GMP  where they compared 
our results with selected protein sequence databases.  
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Figure 4: tandem spectra of lactoferrin peptides obtained by Q-TOF 
mass spectrometry. 
 
 
The highest intensity fragment ions (y-ions in most cases) 
were selected for SRM transitions for each peptide (Table1). 
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1.4.1 c Quantitation using MRM and calibration curves 
The peptides to quantify should have some characteristics, 
first they should be unique, second, peptides with post-
translational modifications (PTMs) should be avoided to 
limit variation across the samples and they should not 
contain deamination or oxidation because these can vary 
across samples.  
From the LC-Q-TOF-MS/MS experiments, MRM 
transitions were developed and they are summarized in 
Table 1 with their respective fragmentation voltages. For 
example: for lactoferrin nine transitions were determinate to 
be optimal:  ([M+2H]
2+
 487.6→m/z 737.4 and 625.3) for 
peptide 93; ([M+2H]
2+
 795.9→m/z 1276.6) for peptide 795; 
([M+H]
+
 621.6→m/z 272.2) for peptide 504; ([M+2H]2+ 
579.3→m/z 771.4) for peptide 544; ([M+H]+ 510.8→m/z 
506.3) for peptide 220; ([M+2H]
2+
 723.4→m/z 731.4) for 
peptide 364; ([M+2H]
2+
 790.4→m/z 1239.5) for peptide 2 
790; ([M+H]
+
 668.4→m/z 300.2) for peptide 5 87.    
 
Part C 
 
160                                   Ph. D. Thesis 
 
 
Table 1:  MRM transitions peptides. 
 
 
Compound Group Compound Name
Precursor 
Ion (m/z)
Product Ion
(m/z)
Ret Time 
(min)
Delta Ret 
Time
Collision 
Energy
ANTITRYPSIN antitrypsin  peptide 1 555.8 797.4 2.92 0.5 18
ANTITRYPSIN antitrypsin  peptide 2 508.3 829.5 3.21 0.5 14
IGA IGA1/2-3 409.7 648.3 1.83 0.5 8
IGA IGA1-2 466.3 415.8 2.3 0.5 15
IGA IGA2-2 582.7 607.8 2.5 0.5 8
IGA IGA1/2-1 607.4 272.2 2.62 0.5 18
IGA IGA1/2-2 448.7 620.3 2.63 0.5 12
IGA IGA2-1 756.9 475.3 2.86 0.5 22
IGA IGA1-1 770.9 475.3 3.23 0.5 20
IGG peptide2_IgG1 419.8 327.7 2.22 0.5 6
IGG peptide1_IgG2 412.8 327.7 2.25 0.5 9
IGG peptide1234_2 418.2 506.3 2.32 0.5 9
IGG peptideIgG3 472.91 534.298 2.5 0.5 6
IGG peptideIgG1234 581.3 243.1 3 0.5 14
IGG peptideIgG1234Q 581.82 244.1 3 0.5 14
IGG peptideIgG1_2 839.41 968.48 3.12 0.5 30
IGG peptideIgG1_3 593.83 699.4 3.18 0.5 20
IGG peptideIgG3_2 604.299 764.9 3.55 0.5 9
IGG IGG peptideIgG2_2 970.14 1100.62 4 0.5 28
IGG peptideIgG1 625.312 836.4 4.12 0.5 12
IGG peptideIgG4 634.98 425.214 4.2 0.5 9
IGG peptideIgG2 636.31 852.403 4.21 0.5 13
IGM IGM 3 534.3 426.3 2.4 0.5 9
IGM IGM 1 639.4 331.2 2.59 0.5 15
IGM IGM 2 572.95 654.9 2.77 0.5 9
IGM IGM 4 789.1 680.9 3.88 0.5 9
J J chain 2 469.8 613.3 2.63 0.5 12
J J chain 1 641.3 1035.5 2.73 0.5 24
lactabumin lactalbumin peptide 1 551.8 932.5 2.87 0.5 18
lactalbumin lactalbumin  peptide  2 836.4 953.4 3.86 0.5 27
Lactoferrin LF peptide 93 487.6 737.4 2.18 0.5 10
Lactoferrin LF peptide 93 487.6 625.3 2.18 0.5 10
Lactoferrin LF peptide 1 795 795.9 1276.6 2.47 0.5 24
Lactoferrin LF peptide 504 621.6 272.2 2.59 0.5 24
Lactoferrin LF peptide 544 549.3 771.4 2.61 0.5 14
Lactoferrin LF peptide 220 510.8 506.3 2.8 0.5 13
Lactoferrin LF peptide 364 723.4 731.4 3.1 0.5 23
Lactoferrin LF peptide 2 790 790.4 1239.5 3.35 0.5 24
Lactoferrin LF peptide 587 668.4 300.2 4.27 0.5 20
Lysozyme lysozyme  peptide 2 788.4 957.5 3.02 0.5 28
Lysozyme lysozyme  peptide 1 700.8 764.4 3.33 0.5 20
Lysozyme lysozyme  peptide 3 788.1 808.4 4.8 0.5 20
SC SC peptide 2 619.7 414.2 2.82 0.5 14
SC SC peptide 5 724.7 860 4.06 0.5 21
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Lactoferrin
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504FDEYFSQSCAPGSDPR
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b5
y4 220DGAGDVAFIR
y7
b5
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Fig. 5 shows the MRM overlaid of all transitions and the 
single extracted ion chromatograms (EIC) monitored 
transitions for all the seven proteins. The LC-MS runs were 
done in 16 minutes and peptides and glycopeptides were 
monitored in the same experiments.  
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IgM
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Figure 5:  MRM overlaid and extracted ion chromatogram.  
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The IgG standard was observed to contain all four IgG  
subclasses: IgG1, IgG2, IgG3 and IgG4, the lactoferrin 
peptide 93, 795, 220, 790 and 587. Four for IgM: IgM1-2-3 
and 4, three for lysozyme, two for antitrypsin and three for 
IgA and J chain. 
For investigation of the assay linearity a dilution series of 
standard peptides containing constant amount of peptides 
were analyzed. Calibration curves were generated by linear 
regression analysis on the peak area ratios versus 
concentration ratios for all peptides. The calibration curves 
(Fig. 6) were fitted linearly with an R
2
 of aost 1. 
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Figure 5: peptides calibration curves.  
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1.4.1 d Glycopeptides quantitation 
Protein glycosylation is one of the most important post 
translational modifications that influence various functional 
aspects of proteins such as structural and modulatory 
functions. Changes in glycosylation have been correlated to 
a number of diseases, including Alzheimer's disease, 
diabetes mellitus, rheumatoid arthritis, and cancer. There are 
two major types of protein glycosylation N and O-
glycosilation. Those where glycan  are connected to 
asparagine residues are named N-linked, and those 
connected to serine or threonine residues, referred to as O-
linked. 
Glycopeptides  were  quantified  using  MRM  in  the  same 
run with the peptides (Fig. 6).  The  absolute  amount  of  
the  proteins was determined using a peptide calibration 
curve, while the degree of glycosylation was normalized to 
the total protein content. The  MRM  transitions  for  all  the  
glycopeptides monitored are shown in Table 2. 
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Figure 6: LC-QqQ profile of peptides and glycopeptides (top); MRM 
chromatogram of glycopeptides (bottom). 
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Compound 
Group
Compound
Name
Precursor
Ion (m/z)
Product 
Ion (m/z)
Ret Time 
(min)
Collision 
Energy
IGA IGA2 3510 205 869.4 204.1 4.85 23
IGA IGA 8200 131/144 934.1 204.1 4.8 29
IGA IGA 9200 131/144 966.5 204.1 4.8 30
IGA IGA 5401 131/144 976.3 204.1 5.2 24
IGA IGA2 5510-205 977.5 366.1 5.2 25
IGA IGA 4501 131/144 984.5 204.1 5.25 31
IGA IGA2 5411-205 1006.8 366.1 5.95 25
IGA IGA 3300 131/144 1015.5 204.1 4.91 32
IGA IGA 5501 131/144 1016.9 366.1 5.15 25
IGA IGA 5402 131/144 1034.5 204.1 5.85 32
IGA IGA 5200 131/144 1045.8 204.1 4.9 33
IGA IGA 3400 131/144 1066.3 204.1 4.83 34
IGA IGA2 5511-205 1074.5 366.1 6.73 25
IGA IGA 5502-131/144 1075.1 366.1 5.85 25
IGA IGA 3510 131/144 1102.8 204.1 5.05 32
IGA IGA1 3500-144 1117.1 366.1 6.4 25
IGA IGA 5400 131/144 1147.3 204.1 4.8 37
IGA IGA 4500 131/144 1157.6 204.1 4.8 31
IGA IGA2 6200-131 1168 204.1 4.8 36
IGA IGA 5301 131/144 1169.3 204.1 5.25 43
IGA IGA 4401-131/144 1179.6 204.1 5.25 41
IGA IGA1 5500-144 1198.1 366.1 4.76 25
IGA IGA1 5402-144 1292.9 366.1 5.9 30
IGG IGG H3N4F1_2 868.1 204.1 2 13
IGG IGG H4N4_2 873.4 204.1 1.98 13
IGG IGG H3N4F1_1 878.8 204.1 1.3 13
IGG IGG H4N4_1 884.1 204.1 1.3 14
IGG IGG H4N4F1_2 922.1 204.1 1.98 25
IGG IGG H4N4F1_3_4 927.4 204.1 1.3 14
IGG IGG H4N4F1_1 932.8 204.1 1.28 15
IGG IGG H3N5F1_2 935.8 204.1 1.98 14
IGG IGG H5N4_1 938.1 366.1 1.28 14
IGG IGG H3N5F1_3_4 941.1 204.1 1.28 15
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Compound 
Group
Compound
Name
Precursor
Ion (m/z)
Product 
Ion (m/z)
Ret Time 
(min)
Collision 
Energy
IGA IGA2 3510 205 869.4 204.1 4.85 23
IGA IGA 8200 131/144 934.1 204.1 4.8 29
IGA IGA 9200 131/144 966.5 204.1 4.8 30
IGA IGA 5401 131/144 976.3 204.1 5.2 24
IGA IGA2 5510-205 977.5 366.1 5.2 25
IGA IGA 4501 131/144 984.5 204.1 5.25 31
IGA IGA2 5411-205 1006.8 366.1 5.95 25
IGA IGA 3300 131/144 1015.5 204.1 4.91 32
IGA IGA 5501 131/144 1016.9 366.1 5.15 25
IGA IGA 5402 131/144 1034.5 204.1 5.85 32
IGA IGA 5200 131/144 1045.8 204.1 4.9 33
IGA IGA 3400 131/144 1066.3 204.1 4.83 34
IGA IGA2 5511-205 1074.5 366.1 6.73 25
IGA IGA 5502-131/144 1075.1 366.1 5.85 25
IGA IGA 3510 131/144 1102.8 204.1 5.05 32
IGA IGA1 3500-144 1117.1 366.1 6.4 25
IGA IGA 5400 131/144 1147.3 204.1 4.8 37
IGA IGA 4500 131/144 1157.6 204.1 4.8 31
IGA IGA2 6200-131 1168 204.1 4.8 36
IGA IGA 5301 131/144 1169.3 204.1 5.25 43
IGA IGA 4401-131/144 1179.6 204.1 5.25 41
IGA IGA1 5500-144 1198.1 366.1 4.76 25
IGA IGA1 5402-144 1292.9 366.1 5.9 30
IGG IGG H3N4F1_2 868.1 204.1 2 13
IGG IGG H4N4_2 873.4 204.1 1.98 13
IGG IGG H3N4F1_1 878.8 204.1 1.3 13
IGG IGG H4N4_1 884.1 204.1 1.3 14
IGG IGG H4N4F1_2 922.1 204.1 1.98 25
IGG IGG H4N4F1_3_4 927.4 204.1 1.3 14
IGG IGG H4N4F1_1 932.8 204.1 1.28 15
IGG IGG H3N5F1_2 935.8 204.1 1.98 14
IGG IGG H5N4_1 938.1 366.1 1.28 14
IGG IGG H3N5F1_3_4 941.1 204.1 1.28 15
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Table 2: MRM glycopeptides transitions. 
 
Compound 
Group
Compound
Name
Precursor
Ion (m/z)
Product 
Ion (m/z)
Ret Time 
(min)
Collision 
Energy
IGA IGA2 3510 205 869.4 204.1 4.85 23
IGA IGA 8200 131/144 934.1 204.1 4.8 29
IGA IGA 9200 131/144 966.5 204.1 4.8 30
IGA IGA 5401 131/144 976.3 204.1 5.2 24
IGA IGA2 5510-205 977.5 366.1 5.2 25
IGA IGA 4501 131/144 984.5 204.1 5.25 31
IGA IGA2 5411-205 1006.8 366.1 5.95 25
IGA IGA 3300 131/144 1015.5 204.1 4.91 32
IGA IGA 5501 131/144 1016.9 366.1 5.15 25
IGA IGA 5402 131/144 1034.5 204.1 5.85 32
IGA IGA 5200 131/144 1045.8 204.1 4.9 33
IGA IGA 3400 131/144 1066.3 204.1 4.83 34
IGA IGA2 5511-205 1074.5 366.1 6.73 25
IGA IGA 5502-131/144 1075.1 366.1 5.85 25
IGA IGA 3510 131/144 1102.8 204.1 5.05 32
IGA IGA1 3500-144 1117.1 366.1 6.4 25
IGA IGA 5400 131/144 1147.3 204.1 4.8 37
IGA IGA 4500 131/144 1157.6 204.1 4.8 31
IGA IGA2 6200-131 1168 204.1 4.8 36
IGA IGA 5301 131/144 1169.3 204.1 5.25 43
IGA IGA 4401-131/144 1179.6 204.1 5.25 41
IGA IGA1 5500-144 1198.1 366.1 4.76 25
IGA IGA1 5402-144 1292.9 366.1 5.9 30
IGG IGG H3N4F1_2 868.1 204.1 2 13
IGG IGG H4N4_2 873.4 204.1 1.98 13
IGG IGG H3N4F1_1 878.8 204.1 1.3 13
IGG IGG H4N4_1 884.1 204.1 1.3 14
IGG IGG H4N4F1_2 922.1 204.1 1.98 25
IGG IGG H4N4F1_3_4 927.4 204.1 1.3 14
IGG IGG H4N4F1_1 932.8 204.1 1.28 15
IGG IGG H3N5F1_2 935.8 204.1 1.98 14
IGG IGG H5N4_1 938.1 366.1 1.28 14
IGG IGG H3N5F1_3_4 941.1 204.1 1.28 15
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Quantitation  of  protein  glycosylation  is  currently limited 
to relative quantitation due to the lack of 
glycan/glycopeptide standards so the glycopeptide signals 
were normalized to the protein abundances to separate out 
the contribution of protein concentration (Eq 2). 
 
 
Degree of glycosilation=
𝐺𝑙𝑦𝑐𝑜𝑝𝑒𝑝𝑡𝑖𝑑𝑒  𝑖𝑜𝑛  𝑎𝑏𝑢𝑛𝑑𝑎𝑛𝑐𝑒
𝑃𝑟𝑜𝑡𝑒𝑖𝑛  𝑖𝑜𝑛  𝑎𝑏𝑢𝑛𝑑𝑎𝑛𝑐𝑒
           (2) 
 
 
 
 
 
 
 
 
 
 
 
 
Part C 
 
172                                   Ph. D. Thesis 
 
1.4.2 Applications 
 
1.4.2 a Milk samples 
Milk samples, previously stored at -80 °C, were completely 
thawed and 50 μL were diluted with 150 μL of AmBic (50 
mM) and subjected to trypsin digestion. Different times and 
enzyme amounts were used to evaluate changes in digestion. 
It was observed that 2 ug of trypsin are sufficient to digest 
50 μL of milk. We tried also to eliminate fat layer from milk 
but there is no difference in digestion. 
No dilution were performed before LC-QqQ analysis. LC-
MRM experiments were carried out employing the method 
previously exposed. Figure 6 shows the LC-MRM profile of 
the peptides find in milk samples. Using Agilent 
MassHunter Quantitative Analysis B 6.0 software the 
response of each peptides was quantified and the 
concentration of proteins, from the corresponding 
calibration curves, was calculated. In tab. 3 have been 
reported the value in g/L found in milk samples. The 
concentration calculated of each proteins are in agreement 
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Milk Protein Calc. Conc (g/L) Theo. Conc (g/L)
Lactalbumin 2.45 ± 0.13 0.4-3
Lactoferrin 0.65 ± 0.05 0.5-6
IgA 0.37 ± 0.05 0.2-2
Antitrypsin 0.075 ± 0.00034 0.05 – 0.3
Lysozyme 0.029 ± 0.0001 0.02-0.4
IgM 0.024  ± 0.0006 0.01-0.2
IgG 0.019  ± 0.0005 0.01-0.2
with literature, for example 0.65 ±0.05 g/L is the quantity 
found for lactoferrin employing our method, the literature 
value is 0.5-6 g/L.  
 
Figure 6: overlaid of LC-MRM profile for each peptides of all proteins.
  
 
 
 
 
 
 
 
Table 3: Calculated and theoretical milk protein concentration. 
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1.4.2 b Feces and urine samples 
50 mg of feces samples were diluted with AmBic 150 μL 
(50 mM), sonicated for 1 h and centrifuged for 30 min, to 
dissolve the most of the proteins. To the top layer was added 
chilled EtOH and placed 1h in -80 °C. The bottom layer was 
dried and reconstituted with AmBic and subject to trypsin 
digestion. In figure 7 is shown the LC-QqQ of the feces 
samples.  
 
 
 
 
Figure 7: overlaid of LC-MRM peptides profile. 
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Most of the concentrations of the proteins found in the feces 
are very low compared to the milk proteins. The only 
exception is α1-antitrypsin, this is in agreement with its 
characteristic, it is a protein that survive digestion. The 
concentration found for the proteins are very close around 
0.2 mg/g for each proteins, α1-antitrypsin is very abundant 
4.6 mg/g and the other immunoglobulins (IgG and IgM) 
were not detected, but also in milk their concentration is 
really low (Table 4).  
 
 
Table 4: feces proteins concentrations. 
 
 
Feces Protein Calc. Conc (mg/g)
Lactalbumin 0.23
Lactoferrin 0.13
IgA 0.18
Antitrypsin 4.6
Lysozyme 0.2
IgM ---
IgG IgG1 and IgG2 peptides 
were enriched
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Urines were soaked in AmBic, extracted and dried. The 
samples were diluted with AmBic and, following the 
procedure, subjected to trypsin digestion and performed on a 
QqQ. Figure 8 shows the profile for the peptide transitions 
in urines. 
 
 
 
Figure 8: overlaid of LC-MRM peptides profile. 
 
 
Also in this case we evaluated the concentration of the 
proteins from the linear regression of the calibration curves. 
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for s-IgA and IgM, IgG 67.1 mg/L, lysozyme 10.4 mg/L and 
α-lactoalbumin and lactoferrin around 2mg/L (Table 3). 
 
 
Table 3: urine proteins concentrations. 
 
 
 
1.4.3 Control and reproducibility of the method 
In a large-scale MRM experiments, the control of the 
conditions and the reproducibility of the HPLC separations 
are critical. We evaluated the plate reproducibility, injecting 
12 times the same sample placed in different position of the 
plate (Fig. 9) and also the injection reproducibility (Fig. 10).  
Urine Protein Calc. Conc (mg/L)
Lactalbumin 0.55
Lactoferrin 1.95
IgA ---
Antitrypsin 278.2
Lysozyme 10.4
IgM ---
IgG 67.1
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Figure 9: Plate reproducibility.  
 
 
Figure 10: Injection reproducibility. 
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1.5 Conclusions 
 
A method was developed to quantify proteins in biologic 
fluid by label free MRM. As expected the quantity of 
proteins in milk, feces and urines are very different and 
reflects their metabolic pathway. Some immunoglobulins 
could not be detected in feces and urine samples as the 
protein concentration is below the detection limit. Our 
results are in agreement with those of literature. 
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1.6 Experimental Section 
 
1.6.1 Materials and Chemicals 
Proteins standards were purchased from Sigma-Aldrich (St. 
Louis, MO). Milk and feces samples were collected from 
healthy patients by UC Davis Medical center; the samples 
were stored at -80 °C prior to use. Sequencing grade 
modified trypsin and dithiothreitol (DTT) were purchased 
from Promega (Madison, WI), iodoacetamide (IAA) was 
purchased from Sigma-Aldrich (St. Louis, MO). 
 
1.6.2 Sample preparation 
1.6.2 a Standards  
Accurate amount of proteins standards were weighed using 
a micro balance (lactoferrin 200 ug, lactoalbumin 200 ug, 
IgA 100 ug, IgG 20 ug, IgM 20 ug, α1-antitrypsin 20 ug, 
lysozime 20 ug) mixted together and dissolved in 300 uL of 
50 mM  NH4HCO3 (AmBic). Sonication was applied for 1 h 
to dissolve the proteins. Proteins were reduced using  4 uL 
of 550 mM DTT (dithiothreitol) in a 60 °C water bath for 50 
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min, alkylated usig 8 uL of 450 mM IAA (iodoacetamide) at 
room temperature in the dark for 30 min. Then 2 ug of 
trypsin was added and proteins were incubated in a 37 °C 
incubator for 18 h. After that the samples were dryed and 
reconstituted with 50 uL of water and diluted serially and 
used to built a calibration curve (Fig. 11 for lactoferrin). 
 
 
Figure 11: dilution serie for lacotoferrin 
 
 
1.6.2 b Milk samples 
50uL of milk samples, from different mothers at different 
stage of lactation, were diluted with 150 uL of 50 mM 
5x10
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
2.2
2.4
2.6
2.8
3
3.2
3.4
3.6
3.8
4
4.2
4.4
4.6
4.8
5
5.2
5.4
5.6
5.8
6
6.2
6.4
6.6
Counts vs. Acquisition Time (min)
2 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 3 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 4 4.1 4.2 4.3 4.4 4.5
b3
y10
y4
b6
504FDEYFSQSCAPGSDPR
b4
y12
544YYGYTGAFR
b5
y4
220DGAGDVAFIR
y7
b5
364VVWCAVGEQELR
790NLLFNDNTECLAR
b3
y10
587LADFALLCLDGK
b3
y9
93LRPVAAEVYGTER
Lactoferrin
Part C 
 
182                                   Ph. D. Thesis 
 
NH4NCO3, reduced with 550 mM DTT (4 uL) in a 60 °C 
water bath for 50 min, and alkylated with 450 mM IAA (8 
uL) at room temperature in the dark for 30 min. The samples 
were digested with trypsin (2 ug) for 18 h in a 37 °C water 
bath. The samples were cleaned up by C18 SPE (solid phase 
extraction), dried, reconstituted with 100 ul of water and 
analyzed on a QqQ, monitoring all the transition determined  
by the standards. 
 
1.6.2 Feces samples 
50 ug of feces was diluted with 150 uL of 50 mM 
NH4NCO3, sonicated for 1h  and centrifuge for 30 min. 300 
uL of chilled EtOH were added to the top  layer and placed 
for 1 h at -80 °C. The top layer was collected to do HMOs 
analysis and  the bottom (100 uL) dried. After reconstituting 
with 150 uL of AmBic, they were reduced with 550 mM 
DTT (2 ul) in a 60 °C water bath for 50 min, and alkylated 
with 450 mM IAA (4 ul) at room temperature in the dark for 
30 min. The samples were digested with trypsin (2 ug) for 
18h in a 37 °C water bath. 
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The samples were cleaned up by C18 SPE (solid phase 
extraction), dried, reconstituted with 100 uL of water and 
analyzed on a QqQ. 
 
1.6.3 LC-MS Analysis 
1.6.3 a Nano-LC-Chip-QTOF analysis 
The peptide samples were reconstituted with 100 ul of water 
and 3 ul was injected for each sample run. The runs were 
carried out on an Agilent 1200 series HPLC-Chip system 
coupled to an Agilent 6520 QTOF (Agilent Technologies, 
Santa Clara, CA). The microfluid chip consisted of two C18 
columns: one for enrichment (4 mm, 40 nL) and the other 
for separation (43 mm x 75 um). The LC separation was 
performed using a binary gradient solvent A of 3% 
acetonitrile, 0.1 % formic acid, solvent B of 90 % 
acetonitrile, 0.1 % formic acid in nano-pure water.  
The MS was operated in positive mode with the parameters 
as follows: drying gas temperature 325 °C, drying gas flow 
rate 5L/min, fragmentor voltage 175 V, skimmer voltage 
65V.  
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The collision energy used for the tandem experiment was 
calculated on the basis of the m/z value using the 
relationship (eq. 1) 
 
    CE (eV)= 1.8 m/z x 100 - 2.4                  eq (1) 
 
 
1.6.3 b UPLC-ESI-QqQ analysis 
The standards were analyzed on an Agilent 1290 infinity LC 
system coupled with an Agilent 6490 triple quadrupole mass 
spectrometer (Agilent Technologies, Santa Clara, CA). 
The LC separation was performed using a binary gradient at 
0.5 ml/min flow rate solvent A of 3% acetonitrile, 0.1 % 
formic acid, solvent B of 90 % acetonitrile, 0.1 % formic 
acid in nano-pure water. The 16-minute gradient used was 
as follows: 0 min at 2.0% B; 15 min at 1.5% B; 3 min at 
25% B; 4 min at 30% B; 10 min at 35% B; 11 min at 40% 
B; the column was washed at 100% B from 12 min to 14 
min and re-equilibrated at 2% B from 14.1 min to 16 min. 
The MS was operated in the positive mode, Q1 and Q3 were 
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operated at unit resolution. The parameters used were: 
drying gas (N2) temperature and sheath gas (N2) temperature 
290 °C, drying gas flow rate 11 l/min, sheath gas flow rate 
12 L/min, nebulizer pressure 30 psi, capillary voltage 1800 
V, fragmentor voltage 280 V, RF voltage amplitude of high 
pressure and low pressure ion funnel were 150 V and 60 V. 
The standards were diluted serially in nano-pure water to 
obtain a calibration curve for protein quantitation. The 
experiments were carried out using the MRM mode, in 
which transitions were monitored only when the target 
analyte was eluted. The cycle time was fixed at 500 ms.  
The MRM result was analyzed using Agilent MassHunter 
Quantitative Analysis B 6.0 software. 
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